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ABSTRACT
Fabrication and characterisation of conducting biomaterials in 3-dimensional
configuration for biomedical applications have been studied and is presented in this
thesis. Different fibre spinning techniques (wet-spinning and electrospinning) were
utilised to create multifunctional fibres to be employed for controlled drug delivery
and cellular growth supports. Two different classes of organic conductors, namely
conducting polymers and graphene, were utilised to induce and develop electrical
and electrochemical features in the fibres for their potential applications in drug
delivery and cell growth enhancement via electrical stimulation. Physical,
mechanical, electrical, electrochemical and biological characterisations of the fibres
were investigated.
In

chapter

two,

Poly(3,4-ethylenedioxythiophene)

poly(styrene

sulfonate)

(PEDOT:PSS) and polypyrrole (Ppy) were utilised in conjugation with chitosan for
fabrication of conducting biocompatible fibres using wet-spinning. Then, a layer of
Ppy with an antibiotic drug Ciprofloxacin hydrochloride (Cipro) as a dopant for Ppy
was produced on the PEDOT:PSS-CHI fibres. The wet-spinning of PEDOT:PSS in a
chitosan coagulation bath was successfully carried out and the fibres were shown to
have an electrical conductivity of 56 ± 7 S/cm with a modulus and strength of
2.0 ± 0.3 GPa and 99 ± 7 MPa, respectively. The PEDOT:PSS-CHI fibres were
subsequently employed as an electrode for the electropolymerisation of Ppy.Cipro on
their surfaces. Scanning electron microscopy (SEM) of the fibres showed the
morphological differences between PEDOT:PSS and Ppy.Cipro layers, confirming
the deposition of the Ppy.Cipro. Cyclic voltammograms of fibres exhibited that the
Ppy.Cipro was electroactive and showed an oxidation and reduction peak at +0.2 V
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and -0.1 V, respectively. The conducting and electroactive fibres were utilised for
controlling the release of Cipro using an electrochemical stimulation protocol. The
results of electrical stimulation of fibres revealed that Cipro release could be tuned
by utilizing the different redox states of PEDOT:PSS-CHI and Ppy.Cipro conducting
polymers. The in vitro antibacterial studies on the fibres and released Cipro
demonstrated that the drug did not lose its antibacterial property during
electropolymerisation and electrochemically stimulated release processes. In vitro
fluorescent staining images revealed that the fibres were not cytotoxic to B35
neuroblastoma cells, however, the cells tended to cluster together rather than attach
to the fibres. Moreover, the results of a lactate dehydrogenase (LDH) test revealed
that the Cipro concentrations released in this study did not have an adverse effect on
B35 neural cell.
In chapter three, the development of a novel and facile system of wet-electrospinning
(combined electrospinning and wet-spinning) is presented. This new method was
developed in order to improve the attachment behaviour of B35 neuroblastoma cells
on wet-spun fibres containing conducting polymers. The process of fibre fabrication
consists of simultaneously wet-spinning and electrospinning to form a structure
composing of micro-size wet-spun fibres coated in nano-sized electrospun fibres.
The new fibre configuration demonstrated increased B35 neuroblastoma cell
attachment as well as promising electrochemical property. Extended electrospinning
times resulted in a thick coating of poly(D,L-lactic-co-glycolic acid) (PLGA) around
the PEDOT:PSS-CHIT fibres which hindered the electroactivity of this conducting
inner core. This was attributed to the thick PLGA coating blocking any ions from
solution interacting with the PEDOT:PSS. This result had implications on the ability
to use these particular fibres in electrical stimulation experiments, and therefore

ii

shorter electrospinning times were investigated.

Additionally, the release of Cipro

from PLGA electrospun fibres has shown the potential of the fibres in drug delivery
applications.
In chapter four, fabrication and characterisation of graphene as an organic conductor
in a wet-spun composite fibres structure was studied to induce and develop electrical
conductivity and electrochemical activity in the fibres. The graphene dispersion
exfoliated in N-Cyclohexyl-2-pyrrolidone (CHP) exhibited dispersion stability over
an extended period of time. The free-standing graphene paper fabricated from the
dispersion (thickness between 5.0 to 100 µm) demonstrated well-defined layered
morphology of graphene. The TEM characterisations of CHP-exfoliated graphene
showed that the graphene dispersion consisted of monolayer and few layers of
graphene. Additionally, the blend of PLGA with graphene was fabricated using a
wet-spinning system. The rheological characterisation of wet-spinning solutions
showed that a concentration of 1.5 wt. % PLGA and above, dissolved in 5 mg/ml
graphene dispersion in CHP, can provide viscosity of ≥ 0.023 Pa s which was found
to be spinnable. The wet-spinning of graphene with the biocompatible PLGA was
carried out successfully with the fibres demonstrating an electrical conductivity of
1.5 S/cm. The PLGA-graphene fibre showed electroactivity in phosphate buffered
saline (PBS) when tested by cyclic voltammetry. The electrical conductivity
measurements showed that, once the graphene content was greater than 11.1 wt. %
(with respect to PLGA), electrical conductivity increased above the percolation
threshold (~30 S/m) and increased to 150 S/m when the graphene content was 24.3
wt. %. The cytocompatibility tests and cryo-SEM images showed that C2C12
myoblast cells were metabolically active on the fibres and attached along the length
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of the fibres. Furthermore, the proliferation assessment over 72 hr on the fibres
revealed that C2C12 cells proliferated along the fibres.
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ABBREVIATIONS

PEDOT:PSS

poly(3,4-ethylenedioxythiophene) poly(styrene sulfonate)

rpm

revolutions per minute

CHI

Chitosan

EG

ethylene glycol

Degrees Celcius

°C

CV

cyclic voltammetry

EIS

electrochemical impedance spectroscopy

SEM

scanning electron microscopy

Ppy

Polypyrrole

PBS

phosphate Buffer Saline

Cipro

ciprofloxacin hydrochloride

UV.VIS

ultraviolet-visible spectrophotometry

Mt

release mass

E.Coli

Escherichia coli

S. pyogenes

Streptococcus pyogenes

DMEM

dulbecco's modified eagle's medium

viii

FBS

fetal bovine serum

Pt

Platinum

ZOI

zone of inhibition

LDH

lactate dehydrogenase

AECM

artificial extra cellular matrix

PLGA

poly lactic-co-glycolic acid

λmax

wavelength of a maximum absorbance

TCP

tissue culture plate

CHP

cyclohexyl-pyrrolidone



extinction coefficient

PVDF

polyvinylidene difluoride

Y

Young’s modulus

σ

tensile strength

ε

breaking strain

TGA

thermal gravimetric analysis

DMSO

dimethyl sulfoxide
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NMP

N-Methyl-2-pyrrolidone

DMF

Dimethylformamide

D

Defect

G

Graphene

TEM

transmission electron microscopy

Ppy.Cipro

polypyrrole doped with ciprofloxacin hydrochloride

PSS

poly(sodium styrene sulfonate)

SWCNT

single-walled carbon nanotube

NaCl

sodium chloride

Hz

hertz, unit of frequency

µl

microliter, a measure of volume 1 µl = 10−6 litre

Ag

silver

AgCl

silver chloride

N

nitrogen

S

sulphur

FTIR

fourier transform infrared spectroscopy

mA

milliampere

x

S

second(s)

min

minute(s)

nm

nanometre, A measure of length 1 nm = 10−9 metres

Py

Pyrrole

hr

hour
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1 INTRODUCTION
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1.1

Thesis outline

Biomaterials are an exciting class of materials that scientists are using in various
biomedical applications such as tissue regeneration and targeted drug delivery. The
term biomaterials consist of two words, “bio” and “materials”, each representing an
immense category in science. The combination of these two categories brings us new
vision in terms of selecting the right precursors, engineering better architectures with
desirable characteristics to enhance and control the interaction of living cells,
determining appropriate therapeutic triggers or development of novel diagnostic
methods.
This thesis describes the fabrication of 3-dimensional conducting biomaterials and
characteristics of organic conductors individually or in combination with nonconductive polymers for different biomedical applications such as controlled drug
delivery and tissue regeneration. Primarily, wet-spinning methods were used to
fabricate composite conducting materials comprising of conducting polymers,
graphene and biopolymers. These materials were tested for cyctocompatibility,
ability to controllably deliver therapeutic agents, and their applications as templates
for cellular growth. In addition, a new combined electrospinning and wet-spinning
system was developed and optimised in order to improve cell adhesion on wet-spun
fibres.
These studies are summarised in the following sections:
In Chapter 1, organic conductors are introduced and selective applications in
biomedical engineering are explained. Conducting polymers (PEDOT:PSS, Ppy) and
graphene as examples of organic conductors were studied and their chemical and
physical reactions have been described in detail. Then, the importance of engineering
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3-dimensional structures has been defined with more details of the fabrication
methods used in this project. The chapter concludes with applications of defined
architectures with the potential for drug delivery and tissue engineering.
Chapter 2 describes the fabrication of 3-dimensional conducting fibres via wetspinning. The characteristics of fibres were investigated electrochemically and
physically using cyclic voltammetry, electrochemical impedance spectroscopy and
mechanical analysis. A novel structure of a double layer of conducting fibres is
introduced which enable loading and releasing biological triggers; in this case the
controlled release of the antibiotic drug, ciprofloxacin, is demonstrated. The activity
of drug and cytocompatibility of conducting fibres are examined using zone of
inhibition and fluorescent staining imaging tests.
In Chapter 3, a combined wet-spinning and electrospinning system is introduced, the
process is a new combination of electrospinning and wet-spinning in continuous
mode. PEDOT:PSS-CHI-PLGA fibres were fabricated and characterised physically
and electrochemically using scanning electron microscopy (SEM) and cyclic
voltammetry techniques respectively. Moreover, improvement in cell attachment on
the fibres produced with the new spinning system has been demonstraed using
Calcein AM and cryo-SEM images.
Chapter 4 investigates graphene as another type of organic conductor. In this work
graphene is synthesised using solvent exfoliation method and its properties have been
characterised. Fabrication of graphene fibres via wet-spinning method blended with
PLGA was performed, and physical and electrochemical behaviours of the fibres
have been investigated using SEM, conductivity measurements and cyclic
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voltammetry. Cytocompatibility of the fibres was tested using fluorescent staining
imaging and cryo-SEM on skeletal muscle myoblast (C2C12) cells.
Chapter 5 concludes the thesis by providing final conclusions and recommendations
for further research. The reader should note that each relevant chapter includes a
short introduction, followed by experimental, results and discussion and conclusion
sections.
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1.2

Materials in biomedical applications

There are a wide range of materials utilised in biomedical applications including
organic and inorganic chemical components, metals, alloys and ceramics. Specific
materials have been commonly applied in different biomedical fields such as
orthopaedics, dental implants, controlled drug delivery, artificial vascular materials
and device housings. In this thesis, the focus is on the role of organic conductors and
polymers as biomaterials for drug delivery and cells growth template. Therefore,
different categories of polymers and organic conductors will be described in
following sections.
1.2.1

Structural polymers

Polymers are a favourite sub-group of organic components, which have been applied
in biomedical fields for decades. The first experiment of cells growth on polymers
template was performed by Vacanti et al in 1988 with harvesting of liver, pancreas
and intestine cells on poly anhydride and poly orthoesters discs [1]. The results
showed that the cells could be cultured on biocompatible polymer without showing
toxicity [1]. It was a promising beginning for the establishment of tissue engineering
science. By introducing the concept of tissue engineering in science, cell growth on
an external template attracted considerable attention. Vast varieties of classic
polymers have been applied for cell growth such as Polycaprolactone (PCL) [2], Poly
lactic-co-glycolic acid (PLGA) [3], Polyurethane (PU) [4], etc by synthesis whereas,
alginate [5], chitosan [6] and collagen [7], etc have been utilised for cell growth from
natural sources. The growth of cells are influenced by various factors such as
substrate composition, architecture, biocompatibility and other external stimuli
including electrical signals, mechanical pulses and presence of growth factors or
other biological agents [8].
5
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Figure 1.1. Chemiccal structurre of poly (llactic-co-gllycolic acid). X is the number of
lactic accid and y is number of glycolic aciid units.
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Uematsu et al. applied PLGA for cartilage regeneration by culturing mesenchymal
stem cells (MSCs) on the polymer scaffold and implanting into a rabbit’s injured
knee [12]. The results demonstrated that the defect area was filled by new cartilage
after 12 weeks implantation [12].
1.2.1.2 Chitosan
A de-acylated derivation of chitin (chitosan) is a type of linear polysaccharide. It has
a very broad range of molecular weights, from 50 to 1000 kDa, that could be tuned
on the basis of sources and preparation procedures [13]. Chitosan is a semicrystalline polymer. Due to its crystalline structure, it normally does not dissolve in
aqueous solution at pH≈7 however, it dissolves in dilute acid (pH≈ 5) easily [13]. Its
cationic nature and high charge density with its enzymatic hydrolysis degradation in
combination with biocompatibility makes it a suitable choice for biomedical
applications. The ability to process it in a porous structure and its applications in
cells transplantation is one of the chitosan features [14]. Chitosan was utilised for
treatment of periodontitis and was absorbed by the host tissue perfectly. It kept its
honeycomb structure based on the evidence received from biopsy of 10 patients [6].
It has also been applied in controlled drug delivery using different methods such as
spheres (micro, nano), spray coating, emulsion droplets [15].
1.2.2

Electro-active materials

Conducting substrates are often utilised as connector between cells and electrical
sources to pass or receive electrical signals to and from cells [16]. In 1791, Luigi
Galvani applied the electrical pulse on muscle for the first time to investigate the
phenomena of “animal electricity” [17]. Conducting platforms include metals (gold,
platinum and stainless steel), or organic conductors (inherently conducting polymers
7

and graphene). It is usually thought that organic materials are electrical insulators.
However, the progress made in chemical synthesis and molecular modification has
brought a rich variety of conducting organic materials [18-20]. These materials can
be classified into inherently conducting polymers and carbon derivatives such as
carbon nanotubes (CNTs) and graphene [18, 21]
The chemical structures, synthesis methods, and electrochemical properties of the
conducting

polymers

used

in

this

work,

specifically

poly

(3,4-

ethylenedioxythiophene) poly (styrene sulfonate) (PEDOT:PSS), polypyrrole (Ppy)
and graphene, will be described in the following sections..
1.2.2.1 Inherently conducting polymers
It is viable to have highly conducting polymers in a charge transfer complex as long
as suitable combination of an organic electron donor or acceptor molecules with
counter-ions or other organic molecules provide charge carriers, known as dopants
[18]. During the chemical doping process, these charge transfer complexes provide
high electrical conductivity [18]. These complexes known as inherently conducting
polymers (ICPs), or synthetic metals, have attracted considerable attention soon after
their discovery by Shirakawa et al. [18]. Subsequently, extensive characterisations of
the ICPs including electrical, thermal and environmental stability as well as their
processability indicate their potential for their use in electronic, renewable energy,
composites and biomedical applications. Over the last 30 years a wide range of ICPs
based on, anilines, pyrroles and thiophenes have been developed [22-25].
ICPs can be polymerised by either chemical [26] or electrochemical [27] methods,
with chemical synthesis being the preferred method when large quantities of polymer
are required. The procedure involves the addition of a strong oxidising agent (such as
8

FeCl3) to the monomer solution [28] to initiate the free radical polymerisation
process. Electrochemical synthesis is typically performed in a 3-electrode cell
comprising of a working, auxiliary and reference electrodes, whereby polymerisation
is initiated by the application of either a voltage or current and an insoluble ICP film
forms on the working electrode, driven by electrostatic forces [29]. This method of
synthesis is usually chosen for research purposes because of the ease of the system
and the ability to have control over of the amount of material deposited. In addition,
using electrochemical polymerisation, it is possible to deposit the polymer on any
shape of electrode and it provides a broad choice of existing dopant ions and the
production of fine quality films [29].
Figure 1.2 shows the polymerisation of polypyrrole (Ppy) (one of the most important
classes of ICPs) from a bulk solution containing pyrrole monomer. The
electrodeposition proceeds by adsorption of a monomer unit onto the surface of the
working electrode, the positively polarised electrode, to form a pyrrole cation radical
through the oxidation process. These cations combine together or with neutral
monomers present in the solution [30] to form a dimer, which undergoes double
deprotonation to provide a neutral molecule. Dimer radicals are more stable and have
a lower oxidation potential compared with the monomer units and polymer chain
growth then occurs by favoured coupling between the dimers and monomers. The
electrical conductivity and chemical stability of ICPs occurs as a result of extended
π-conjugated backbone and its hetero aromatic structure [30]. As positive charges are
developed along the polymer during polymerisation, the incorporation of negatively
charged counter-ions become necessary to maintain charge balance within the ICP
backbone. This latter process is known as doping [31].
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The conductivity of ICPs can be enhanced to metallic levels by chemical or
electrochemical `p-doping' (oxidation) [22], or `n-doping' (reduction) [22]. The
conductivity enhancement of ICPs is due to movement of electrons along the
backbone of the polymer after the doping process [29]. During oxidative doping of
ICPs, “holes” are created throughout the polymeric chain and electrons move freely
to these holes and it assists electron movement and conductivity eventually [29]. This
hole, which is basically a molecule or part of a macromolecular chain containing two
positive charges in the conjugated system (known as bipolaron), is responsible for
high conductivity of an ICP after oxidative doping [19].
In contrast with metals, the electrical, electrochemical and physical properties of
ICPs can be tailored for particular applications by changing the dopant and doping
process [19, 32, 33]. ICPs have been utilised for biosensors [34], drug delivery [35],
cells host template [36], and stimulation of cells or tissues to enhance cells survival
or direction [37]. ICPs such as PPy and PANI are not biodegradable; therefore they
are often used in combination with other biodegradable polymers such as PLGA,
PVA and PCL for use in biomedical applications, where biodegradability required.
Polypyrrole is one of the most preferred conducting polymer used in biomedical
applications due to its ability to be synthesised at neutral pH and its ability to support
cell growth. Rivers et al. used the strategy of tethering conductive pyrrole-thiophene
oligomers to degradable ester linkages using an aliphatic linker. They demonstrated
that these ICP-blends were biocompatible with human neuroblastoma cells and that
they also demonstrated degradability in PBS [38]. Conducting polymers including,
PEDOT have been utilised in cellular growth support and implantable cochlear [5,
39]. Several studies have also reported utilising PANI [40-43] and PT [44] as
cellular growth templates and neural electrode respectively.
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Figure 1.2. Mechanism of polypyrrole polymerisation

1.2.2.1.1 Polypyrrole
Polypyrrole (Ppy) is an ICP which has been greatly explored due to its high electrical
conductivity, biocompatibility, low production cost and suitable environmental
stability [42]. Ppy has been considered in a variety of applications including,
capacitors [23], electronic devices [45], actuators [46], sensors [47], corrosionprotection materials [48], electrochromic devices [49], electrodes for rechargeable
batteries [50], super capacitors [51], controlled drug delivery [52], 3D scaffold [39].
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The oxidation potential at which pyrrole is polymerised into Ppy is normally above
+600 mV versus an Ag/AgCl reference. The morphology and electrochemical
property of the resulting film depend on several processing parameters including the
nature of supporting electrolyte, crystallographic structure of underlying anode,
potential used for deposition, nature of dopant, monomer concentration, temperature
and pH of the solution [53, 54]. Figure 1.3 illustrates some examples of different
surface topographies due to variation of counter-ions and synthesis durations. The
shorter polymerisation times (10 min) (A, C, E and G) create thin films with very
little surface features while at longer times (60 min) (B, D, F and H), thicker films
with distinctive topography are observed [55].
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Figure 1.3. SEM images of Ppy surface topography as a function of counter-ions and
electropolymerisation durations. Left column is short time (10 min) synthesis while
right column is longer polymerisation duration (60 min). (A–B) Ppy/chloride, (C–D)
Ppy/polyvinyl sulphate, (E–F) Ppy/dextran and (G–H) Ppy/collagen (Figure adapted
from Ref.[55]).
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The interaction of the polymer conjugated chain is strong resulting to the insolubility
and infusibility of Ppy. In addition, the ionic interaction between the oxidised
segments of the Ppy chains also contributes to the insolubility of doped Ppy [28].
Ppy can undergo a dedoping and doping process involving either chemical or
electrochemical processes. Through this doping process the conductivity of neutral
Ppy is enhanced from insulator to a metallic state due to the tuning of the Ppy band
gap. This feature is one of the advantages of conducting polymers over metals when
there is a need to control the electronic properties of the material [56]. Figure 1.4
shows the doping process of Ppy from a neutral and non-conductive state of Ppy with
the benzenoid structure to the metallic and conducting state. In the neutral state
(Figure 1.4-A), the band gap of Ppy is 3.6 eV, making it difficult for electrons to
transfer from the valence to the conduction band. Upon doping and extraction of the
first electron from the neutral part of a Ppy chain, the quinoid resonance becomes
favourable (Figure 1.4-B). The presence of a positive charge and an unpaired
electron are referred to as a polaron with the spin of 1/2. After removing the second
electron by further oxidation of the Ppy chain, a bipolaron is formed; which is
broadly more encouraged than formation of two polarons (Figure 1.4-C). Each
bipolaron usually extends over four pyrrole rings and sets the polymer chain to zero
spin [56].
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Figure 1.4. Doping/dedoping of Ppy. A) neutral, B) polaron in partially doped, and
C) bipolaron in fully doped polymer.

The ability to polymerise Ppy at neutral pH in aqueous solutions makes it an
appropriate polymer to include biological molecules and living cells within its
structure [57].For example, Ppy with functionalised chondroitin sulphate (CS), an
extracellular matrix molecule, has advantages for different biomedical and organic
bioelectronic applications, such as cell stimulation, as it allows facile incorporation
of bio-regulative cues to provide bio-mimicry and conductive environments for
promotion of cell functionality [58].
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1.2.2.1.2

PEDOT

Poly (3,4-ethylenedioxythiophene) (PEDOT) is an ICP from the polythiophene
family and possesses a low band gap (between 1.4 to 2.5 eV) and is
electrochemically and thermally stable [59]. In particular, PEDOT:PSS has been
utilised in a wide range of applications including transparent conducting electrodes,
antistatic coatings, electrochromic devices, organic photovoltaic devices, inkjet
printing, rechargeable batteries, super capacitors, sensors and fibre spinning [60-64].
One of the most commonly used PEDOTs is the polymer doped with PSS
(PEDOT:PSS) and can be synthesised either chemically [65] or through
electrochemical polymerisation [66]. The conductivity of PEDOT:PSS depends on
the method of polymerisation used and/or post-treatment of PEDOT:PSS with other
reagents such as ethylene glycol (EG) [3]. In the chemical method, the EDOT
monomer is mixed with an oxidant such as ferric chloride with polymerisation
leading to highly conducting PEDOT whilst, in electrochemical polymerisation
EDOT monomer is polymerised using a three electrode cell.
PEDOT has been utilised in biomedical applications such as cells host template [67],
biosensor [68] and neural prosthetics [69]. PEDOT film was able to control cells
density gradient which influences cells interaction with their neighbour environment
for

intracellular

interaction
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[70].

1.2.2.2 Graphene
Graphene is a two-dimensional single atom thick monolayer of carbon, which is
tightly packed in a honeycomb crystal lattice of sp2-bonded carbon [71, 72]. This
structure is the basic building block of all other graphitic nanostructured materials
[71]. As shown in Figure 1.5, if it is wrapped up into 0D it will form a fullerene,
rolling into 1D makes a nanotube or if stacked into 3D it builds graphite [21]. 2D
graphite (or graphene) has been the subject of theoretical studies for over 60 years
[73]. The theory behind graphene was first introduced by the theoretical physicist
Philip Wallace in 1947 [73] and was then further explored by Hanns-Peter Boehm,
who described single-layer carbon foils in 1962 [74]. However, not much attention
was given to practical applications of graphene due to the fact that it was presumed
not to exist in the free state [71]. It was believed that graphene was unstable with
respect to its curved structures such as nanotubes and was described as an ‘academic’
material [75]. This was until isolation of individual graphene planes was realised
using micromechanical cleavage by Novoselov et al. [72].
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Figure 1.5. Graphene is a 2D building material for carbon materials of all other
dimensions (Figure adapted from ref.[21]).

The unique electronic properties of isolated layers of graphene were measured [72]
and its outstanding electronic [76], mechanical [77], thermal [78] and chemical
properties were realised resulting in graphene receiving increasing attention in the
scientific community. Therefore, graphene became an interesting candidate for a
wide range of applications including composites [79], optics [80] and electronic
devices [81]; however, the first step to exploit these superlative properties of
graphene is its synthesis on a large scale with low cost, high yield, reliable, mild
environmentally friendly method.
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Graphene was initially produced by micromechanical cleavage of bulk graphite,
which involves peeling off layers of highly ordered pyrolitic graphite (HOPG) using
scotch tape and then depositing on to a silicon wafer [72]. Although this method can
produce high quality graphene with dimensions as high as 10 µm, both the yield and
throughput are extremely low. More recently, other methods such as mechanical
exfoliation [72], epitaxial growth [82], unzipping of carbon nanotubes [83], single
layer graphene growth on carbon melts [84], pyrolysis of ethoxides [85], graphene
processing of sucrose [86], chemical reduction of graphene oxide (GO) [87, 88] and
liquid phase exfoliation of graphite [89] have been developed.
So far, the most promising method for production and processing of graphene is
solution based graphene which is advantageous in terms of yield, cost and
performance [87]. To this end, one of the most efficient methods for large scale and
low-cost production of graphene is oxidative exfoliation of natural graphite followed
by chemical reduction [90, 91]. The oxidation process introduces various functional
groups such as hydroxyl, epoxide, carbonyl and carboxyl in-plane and around the
edges of graphene crystals [92]. These functional groups make GO hydrophilic and
dispersible in aqueous media. Reduction processes removes most of the chemical
functional groups and renders reduced graphene oxide (rGO) hydrophobic and
insoluble in aqueous media. The former product is conducting but its low solubility
sometimes causes irreversible aggregation and limits further processing. Although
the chemical reduction method is a practical and high throughput method for making
graphene, a significant amount of irreversible lattice defects are introduced by the
oxidation process, which adversely affects the electronic properties of graphene [93,
94]. Liquid phase exfoliation of graphite using surfactants or organic solvents
provides a practical method to produce a significant amount of defect-free, high
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quality monolayer or few layers un-oxidized graphene [95]. This method deals with
exfoliation of powdered graphite with the aid of sonication to give graphene in the
liquid phase without any additional oxidation steps [96].
Table 1.1 compares some of the researches that have been carried out to produce
graphene through the solution exfoliation of graphite. In this method, graphite source
(i.e graphite powder) is added to water (containing dispersant) or organic solvent
followed by sonication (bath, probe). The choice of surfactant or dispersant as
stabilizer is important with surfactants such as SDBS [97], sodium cholate [96], 1pyrenemethylamine hydrochloride [98], perylene-based bola amphiphilic detergent
[99], and 7,7,8,8-tetracyanoquinodimethane [100] being utilised for successful liquid
phase exfoliation of graphene and few layers of graphene. Probe sonication required
much lower processing time (up to 4 hr), while the bath sonication was applied for
up to 400 hr. The advantages of the bath sonication over the probe sonication are the
formation of less defects and production of larger graphene flakes [95, 101-103].
NMP and DMF were the most effective solvents for dispersing graphene when
concentrations higher than 1mg/ml were obtained after bath sonication of up to 400
hr [101]. Liquid phase exfoliation of graphite results in a mixture of graphite, fewlayers graphene and mono-layer graphene. Large particles have been removed
through the use of centrifugation. Different centrifugation speeds (from 500 rpm to
13000 rpm) and durations (from 30 min to 90 min) were applied (Table 1.1).

20

Table 1.1. Comparison of different methods for production of liquid phase exfoliated graphene
Graphite precursor

Dispersant

Sonication

Sonication

Centrifugation

Centrifugation

Graphene

method

time

speed

time

concentration

(h)

(rpm)

(min)

(mg ml-1)

Solvent/surfactant

Application

Reference

Natural graphite

N-methyl-pyrrolidone (NMP)

Bath

0.5

500

90

0.01

Transparent thin film

[95]

Natural graphite

Dimethylformamide (DMF)

Probe

3

13000

10

-

Liquid crystal devices

[104]

Natural graphite

Hexafluorobenzene

Bath

1

-

-

0.05-0.1

-

[105]

Different types

Ortho-dichlorobenzene

Probe

0.5

4400

-

0.02-0.03

-

[106]

Natural graphite

40

Bath

0.5

500

90

Up to 0.008

-

[107]
[108]

Different solvents
Natural graphite

Sodium cholate

Probe

-

15000

60

0.09

Transparent thin film

Expanded graphite

NMP

Probe

0.5

600

30

Up to 0.1

-

[109]

Natural graphite

1-Hexyl-3-methylimidazolium

Probe

Up to 24

-

-

Up to 5.33

-

[109]

Highly ordered pyrolytic

Cetyltrimethylammonium

Probe

4

-

-

-

-

[110]

Graphite

Bromide in DMF

Natural graphite

Sodium dodecylbenzene

Bath

0.5

500

90

Up to 0.1

-

[97]
[103]

Hexafluorophosphate

Sulfonate
Natural graphite

NMP

Bath

Up to 460

500

90

1.2

-

Natural graphite

Sodium cholate

Bath

Up to 400

500

90

0.3

-

[96]

Natural graphite

n 1-Propanol

Probe

0.3

4500

10

0.025

-

[111]

Natural graphite

Chloroform and

Bath

Up to 300

2000

45

0.5

-

[112]

Isopropanol
Natural graphite

Organic solvents and NaOH

Probe

1.5

3000

60

0.07

-

[113]

Natural graphite

NMP, DMF

Bath

Up to 400

500

90

>1

Low defect graphene

[101]

Expanded graphite

NMP

Probe

2

3000

90

Composite with PU

[114]

Natural graphite

NMP

Bath

144

1000

45

Composite with

[115]

-

Polyethylene Terephthalate
and SWNTs
Natural graphite

PVA

Bath

100

1000

21

45

-

Composite with PVA

[116]

Direct exfoliation of graphite is also possible by utilising organic solvents [105, 112].
The advantage of using organic solvents over surfactants is the avoidance of the
addition of dispersing agents, which can cause adverse effect on the electrical
properties of graphene. NMP has been reported as the most effective solvent for
graphene, dispersing more than 1 mg/ml of graphene and few layers graphene after
460 hours mild sonication [103]. Figure 1.6 shows transmission electron microscopy
(TEM) images of solvent (NMP) exfoliated graphene [103]. Figure 1.6-A shows a
graphene monolayer whereas Figure 1.6-C shows a multilayer [103]. Utilising TEM
images provides the possibility to do edge-counting to evaluate the number of
graphene layers. The well-defined edges are representative of graphene monolayer
while multilayers, typical of larger objects, are observed regularly [103]. It should be
noted that, very thick multilayers also can be observed and these need to be removed
by subsequent centrifugation [115]. Another confirmation for the presence of
graphene monolayer is analysis of the electron-diffraction patterns, such as that
presented in the inset of Figure 1.6-A [103]. Confirmation of graphene monolayer
occurs when the inner spots are more intense than the outer spots [95].
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Figure 1.6. TEM images of solvent exfoliated graphene flakes. A) A typical
monolayer. Inset: a diffraction pattern taken from the monolayer. B) One few layers
graphene, and C) a magnification of the part identified by a dashed box in image B.
The arrows in this image demonstrate the spot of the edges of the individual sheets
comprising this multilayer. D) A wide-field image illustrating the bulk quantities of
graphene prepared after long sonication times (180 h) (Figure adapted from ref.
[103]).

The choice of solvent is crucial during the exfoliation process, as no dispersing agent
is used. Coleman et al. investigated the dispersability of graphene in 40 solvents and
suggested that good solvents for graphene are characterised by surface tensions close
to 40 mJ/m2 (equivalent to surface energies of ∼70 mJ/m2) and Hildebrand solubility
parameter close to 23 MPa1/2 [107]. Figure 1.7 compares the effectiveness of solvents
to disperse graphene as a function of the solvent surface energy. According to this
graph, NMP and DMF (their chemical structure are shown in Figure 1.7) are the
most effective solvents to disperse graphene [101].
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Figure 1.7. Graphene concentration as a function of solvent surface energy. The
chemical structure of NMP (left) and DMF (right) are presented in the graph (Figure
adapted from ref. [101]).

Centrifugation is another key point affecting the quality of graphene dispersion, by
separating large aggregate particles and non-exfoliated graphite from monolayer/few
layers graphene. Higher centrifugation rate and duration were found to produce
better quality graphene sheets, but smaller size with lower concentration [96, 103].
The sonication method and condition also play important roles in production of
solvent exfoliated graphene. Both intense tip sonication for short time and mild bath
sonication for long periods have been used to produce graphene in organic solvents
or in water [102]. Tip sonication method is fast but introduces more lattice defects to
the graphene whereas bath sonication is time consuming, but, causes less defects [96,
108]. In order to enhance the efficiency of production procedure, it is also possible to
utilise different graphene precursors such as thermally expanded graphite (EG) [106]
and functionalised graphite such as fluorinated graphite [117].
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One of the main advantages of the solution processing method for producing
graphene, in contrast with other methods, is the easy processing of the final product
[118]. Processing in solution not only permits the fabrication of paper like structures
(Figure 1.8) and/or thin films but also, permits the introduction of graphene into
polymer host material and simplifies the fabrication of composites [119]. The
graphene paper shown in Figure 1.8, afforded high electrical conductivity and tensile
strength of 180 S/cm and 15 MPa, respectively [103]. As such, solvent or surfactantexfoliated graphene has the potential to be employed in many applications in both
research and industry.

Figure 1.8. A) photograph of a free-standing paper prepared from solvent exfoliated
graphene. B) SEM image of the edge of the paper in (A). C) Close up image of (B)
(Figure adapted from ref. [103] ).

A summary of the fabrication of three-dimensional structures for biomedical
applications is presented in the following sections.
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1.3

Fabrication

The fabrication techniques and utilising of 3-dimensional structures for assessing
biological based applications are rising due to the inability of 2-dimensional
structures to accurately mimic the extracellular matrix (ECM) [120]. In biology, the
extracellular matrix is a part tissue in 3D form, which supports cells attachment and
their functionalities [120]. Parameters such as geometry, biocompatibility,
mechanical properties and surface properties [7] need to be carefully considered
when designing three-dimensional architectures for biomedical applications.
Structures that have circular [121], tubular [4] and nano [122] architectures show
similarities with human ECM, therefore are favourable for tissue engineering
applications.
The following sections describe the fabricated structures that have been utilised in
this thesis.
1.3.1

Wet-spun fibres

Fibres are another class of 3-dimensional structures, which are the primary product in
the garments industry. Wet-spinning is a particular industrial method to produce
continuous fibres during extrusion of synthetic or naturally made fluid polymers into
a spinneret followed by injecting into a coagulation bath which could be water based
or organic solvent based. During this process, first, the polymer fluid is being
converted into a rubbery gel state and then, to a solid-state fibre. This process of
extrusion and solidification/coagulation of filaments is called wet-spinning [123,
124]. Wet-spinning is the oldest spinning method and was initially used for the
spinning of rayon fibres [123]. Rayon was the first man-made fibre spun from a
synthetic polymer in the 19th century. Prior to this, the spinning precursors were
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limited to naturally occurring materials [123, 124]. The principle of wet-spinning
(Figure 1.9) relies on the coagulation precipitation of a fluid polymer to form a fibre;
with rayon, aramid, acrylic, modified acrylic, polyaniline and spandex fibres all
being manufactured by this process [123, 124].

Figure 1.9. Schematic of wet-spinning technique used in this thesis to produce wetspun fibres.

Wet-spinning can be sub-divided into three methods based on different spinning
strategies as follows: (i) phase separation, (ii) gel formation and (iii) liquid crystal
spinning [123]. (i) During phase separation (sometimes referred to as non-solvent
method), fibre formation occurs rapidly as the polymer fluid is injected through the
spinneret into a coagulation bath. As the polymer fluid is exposed to the non-solvent,
the solvent is extracted from the polymer solution and this causes the polymer to
coagulate in the bath, then precipitate to form a semi-solid fibre. This process is
followed by further solidification into the coagulation bath to provide sufficient
cohesion and strength for the fibre to be collected continuously out of the coagulation
bath. (ii) In the gel formation method, the polymer solution is coagulated due to
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intermolecular bonds such as ionic cross-linking by a salt or other reacting agent. (iii)
In the case of liquid crystal spinning, lyotropic liquid crystalline solution provides
sufficient alignment and cohesiveness for fibres to form a solid crystalline phase. The
ultimate physical properties of wet-spun fibres are influenced by a number of process
and solution parameters such as solution viscosity and concentration, coagulation
strategy, pumping rate, pH, temperature and winding speed [123, 124].
While wet-spun fibres were utilised in tissue regeneration [125], their applications in
other fields of biomedical engineering such as drug delivery [126] are under
progress. Flexibility, appropriate mechanical properties, processability into devices
by knitting and braiding methods provide huge opportunities for wet-spun fibres to
be utilised in biomedical fields. For example, PLGA wet-spun fibres were knitted
and braided into artificial anterior cruciate ligament (ACL) structures by Larencin et
al. [127]. PLGA wet-spun fibres possessing appropriate biocompatibility and
mechanical properties have been braided into scaffolds which exhibited cells
attachment efficiency for ligament replacement [127]. Razal et al. wet spun
hyaluronic acid (HA) and chitosan (CHI) with carbon nanotube (CNTs) to form a
composite fibre that was shown to support the growth of L-929 mouse fibroblast
cells [125]. Cell adhesion to the fibres was promising and they mimicked the
geometry of the wet-spun fibres [125]. Lee and colleagues developed a method to
fabricate PLGA micro-fibres as platforms for tissue regeneration [128] by
precipitating a solution of PLGA prepared in DMSO into a glycerol-containing water
solution in PDMS-based micro fluid system, and cultured L-929 fibroblast on the
surface of fibres without fibronectin up to 3 days. Cell attachment to the fibres
structure and their alignment proved the potential of wet-spun fibres in tissue
engineering [128].
28

In addition, wet-spun fibres can be used as a substrate for drug delivery [126].
Biological molecules such as therapeutic drugs or growth factors can be incorporated
into and/or onto fibres with ionic, covalent bonding or by physical blending into
polymer solutions prior to forming the fibre [129]. Mack et al. utilised PLGA wetspun fibres as platforms for controlled release of levofloxacin and dexamethasone
using the degradation property of PLGA [126]. They implanted certain lengths of
fibres containing levofloxacin into the eye of rabbits. The burst release of the drug
was detected through the rabbit’s tears, and correlation between in vitro and in vivo
levofloxacin release profiles was demonstrated. The burst release of levofloxacin was
favourable, as a high amount of drug is needed right after implantation. Fibres can
also be knitted or braided into mats or cylindrical platforms to accommodate a range
of different applications in biomedical engineering.
1.3.2

Electrospun fibres

Nanotechnology provides a means to advance the fabrication of sub-micron or nanostructured 3D dimensional structures [130]. Combining nanotechnology with microscale fabrication processes provides the opportunities to discover new aspects of
materials for tissue engineering, diagnosis and monitoring [131]. Electrospinning is
one of the versatile methods for production of sub-micron or nano-scale fibres, which
greatly facilitates the fabrication of biomaterials [131].
Doshi and Reneker were the first researchers in 1995 to report the electrospinning
method to produce nanofibres [132]. Electrospinning requires a high voltage power
supply (up to 30 kV), syringe pump and conducting collectors (target). In a typical
electrospinning process, a high voltage is applied between a droplet of polymer
solution, extruded from the tip of a metal syringe needle, and a grounded target
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[133]. Upon applying the electrical voltage, electrostatic charge forms on the surface
of the polymer droplet and increases as the voltage is increased until the electrostatic
charge overcomes the surface tension of the droplet upon which a charged polymer
fluid jet is ejected toward the target. The jet exhibits bending instabilities due to the
repulsion of mutual surface charges, which is carried by the jet, and follows a
looping and spiral path (Figure 1.10). This repulsion elongates the jet thousands of
times so that it becomes extremely thin. Eventually, the solvent evaporates and long
nanofibres are collected on the grounded target.

Figure 1.10. A) Schematic of electrospinning set-up. B) Photograph of the
electrospinning jet.
The morphology and diameter of electrospun nanofibres are dependent on a number
of processing and solution parameters [134] as follows: (a) the intrinsic properties of
the solution such as the type of polymer and solvent, polymer molecular weight,
viscosity (or concentration), elasticity, conductivity, and surface tension, and (b) the
operational conditions such as the applied voltage, the distance between spinneret
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and collector (tip-target distance), and the feeding rate of the polymer solution.
Additionally, the morphology and the diameter of electrospun nanofibres are affected
by ambient humidity and temperature [134]. For example, for the electrospinning of
poly (ethylene oxide) (PEO), the concentration of polymer solution must be high
enough (between 298 to 1835 cP) to afford polymer entanglements, but not so high
that the viscosity prevents polymer motion induced by the electric field. The lower
surface tension (~ 76 mN/m) and higher electrical conductivity of spinning solution
(between 200-250 Ω m) are also favorable [135].
Due to the chaotic oscillation of the electrospinning jet, the nanofibres are usually
collected as a nonwoven mat, which are used in various applications such as
filtration [136], tissue scaffolds [137], wound dressing [138], and drug delivery [139,
140]. However, in some of the biomedical applications where cell alignment is
favourable, well-aligned and highly ordered nanofibres are required [141, 142].
Different geometries such as highly aligned [143], yarns (twisted [144] or untwisted
[145]) and arrays [146] of electrospun fibres have been achieved by modifying the
electrospinning set up. There have been many attempts to achieve aligned nanofibres
either with electrostatic or mechanical forces. Oriented polyamide nanofibres
formation was demonstrated by Dersch et al. as a result of the polymeric jet moving
back and forth on the collecting site due to electrostatic forces [147]. In the other
method, aligned polyethylene oxide nanofibres were collected on the rotating drum
in aligned and cross-bars shape [148].
Electrospinning of PEDOT:PSS has been performed from a mixture with other
polymers such as polyvinylpyrrolidone (PVP) [149] and polyacrylonitrile (PAN)
[150], as polymerisation templates in different polymerisation methods such as
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vapour phase [149] and electrochemical polymerisation [151]. The versatility of
electrospinning and nanofibres helps in designing more appropriate structures when
fibres are required for biomedical research. Although the electrospinning and wetspinning system has led to the fabrication of fibres with low mechanical properties,
the fibres can be modified by addition of different additives such as polymers (e.g.
PLGA, PCL, and chitosan), carbon nanotubes or graphene. Moreover, the feasibility
to tune the morphology in terms of design, size and thickness facilities generation of
fibres with increased mechanical properties [152, 153]. Many studies have been
published where the formed fibres have been evaluated for their implant
biocompatibility. Shin et al. has shown that electrospun fibres were biocompatible
when implanted into the omenta of rats for 4 weeks [154]. In addition Requicha et al.
showed similar biocompatibility after implanting wet-spun fibres into 10-weeks old
Wistar rats [155]. These studies clearly demonstrate the biocompatibility of these
produced fibres with not inflammatory response reported. The following section
describes in detail the role of 3D structures in different architectures in biomedical
engineering.
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1.4

Biomedical Applications

Artificial extracellular matrixes (AECM) have been designed and fabricated to
support the growth of cells and eventually be utilised in tissue regeneration [156]. In
order to reduce post-surgery inflammation and infection, biomaterial scaffolds have
been designed to incorporate drugs in the structure [157].
1.4.1

Drug delivery

Drug delivery is a technique or process to deliver therapeutic triggers such as drug,
protein, growth factor and enzyme, into target organs in a desirable release profile in
animal or human [158, 159]. Localised drug delivery offers several advantages over
conventional oral or parenteral (systemic) dosage forms. First, localised delivery
allows site specific drug administration where the drug is needed most. Examples
include implants used in the treatment of brain tumors or prostate cancer. This may
also allow for significantly lower doses of the drug, which can minimize potential
side effects. In addition localised delivery systems minimize drug degradation and
loss, increase drug bioavailability and the fraction of the drug accumulated in the
required zone. These advantages have led to increase research activity in the
development of various drug delivery and drug targeting systems.[160]. Although,
traditional delivery systems (orally or semi-localised) are still the current methods for
treatment of diseases, new drug delivery methods are in the central focus of
researches to achieve highest therapeutics efficiency with lowest side effects [161].
Advances in the design of biocompatible structures with capability to maintain
different therapeutic triggers, in conjunction with knowledge of diseases mechanism,
led to the creation of different delivery systems either in biodegradable or nonbiodegradable strategies [129]. In biodegradable structures, therapeutic components
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are released with the assistance of degradation, diffusion and dissolution, however, in
non-degradable materials, external factors such as electrical stimulation [159], pH
[162], light [163] and mechanical signals [164] are the main elements to drive the
release process.
1.4.1.1 Drug delivery from degradable polymers
Biodegradable polymers are attractive materials for drug delivery since, once they
have performed their drug delivery role they degrade away [165]. Degradation of
these polymer types occur when the release medium penetrate the polymer structure
and in turn breaks down the polymer backbone and converts it to simple components
[166]. Several factors such as molecular weight, chemical composition, structural
configuration and physicochemical factors (i.e., ionic strength and pH) influence the
degradation rate of polymers [167]. Poly lactic-co-glycolic acid (PLGA) is one of the
most common degradable polymers applied in a variety of biomedical applications in
a wide range of architectures due to its biocompatibility and processability [168].

Bodmeier et al. investigated the release of progesterone from poly (D-lactic) films
and studied the release kinetics of progesterone due to degradation of the polymer.
The results showed that 0.8 μg of progesterone was released during the first 60 min
of the experiment followed by the release profile plateauing out [169]. Multilayers of
chitosan-PLGA-chitosan were fabricated and loaded with ipriflavone and compared
to monolayer films of PLGA and chitosan and characterised in vitro. In addition, the
drug release properties over 20 days from chitosan-PLGA-chitosan structures were
shown to be biocompatible in vitro [170].
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Drug delivery from a biodegradable polymer usually resulted in a sustained release
profile, however, in some medications patients need to have a higher concentration
of drug in specific time points. In these cases, other drug delivery systems need to be
considered.

1.4.1.2 Drug delivery from conducting polymers
Controlled delivery of drugs from a conducting platform was performed for the first
time in 1984 [171]. This process entailed passing electrical charge through the
platform loaded with the drugs. This electrical stimulation triggered a response in the
conducting materials such that the drug is released. To use electrical stimulation to
release incorporated drugs in a controlled way, the material must be conducting and
more importantly, their conductivity should not change during the release process
[172]. In order to tune the release profile of therapeutics components, electrical
stimulation can be applied to the conducting material with direct connection [29].
It is important to know if the drug of interest for the intended application is itself
electroactive and likely to be influenced by the magnitude of the applied electrical
stimulation [161]. In addition, the pKa of the drug should be considered as this will
influence the incorporation and release of drug from the conducting platform [173].

Conducting materials that have been utilized in drug release include functionalised
metal (e.g., gold and silver) [174], conducting polymers [175] and carbon
nanostructures [176] (e.g., carbon nanotubes and recently graphene). The use of
conducting polymers and other carbon nanostructures are becoming more desirable
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for drug delivery since polymers have softer and more flexible surfaces than metals
[157, 161]. The mechanism for drug release is proposed to involve electrostatic
interactions as the application of electrical stimulation protocol changes the amount
of drug release [52]. Figure 1.11 shows the schematic reaction associated with the
electrochemical polymerisation of PPy. During polymerisation (Figure 1.11. A) the
negatively charged A- molecules (that can be a drug) acts as counter ion and is
incorporated into PPy structures during synthesis. Drug release from the PPy
structures can be facilitated by applying a reducing potential to the polymer (Figure
1.11. B).

Figure 1.11., A) Synthesis of ICP showing the incorporation of the dopant A−. B,
Release of the dopant A− during redox cycling of the ICP. Figure adapted from ref
[52].
Table 1.2 presents some of the significant works that have utilised conducting
polymers for controlled release of biomolecules. The delivery of nerve growth
factors has also been demonstrated from conducting polymer films via electrical
stimulation [177, 178]. These studies showed that Ppy could incorporate and release
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the nerve growth factors NT3 and BDNF using electrical pulses or constant currents
and potentials. It is also reported that different types of counter-ions (anionic [179],
cationic [158] and neutral [180]) can be incorporated during electropolymerisation
therefore, anionic drugs according to their chemical structure can be utilised as a
dopant in electropolymerisation, and cationic and neutral drugs can be associated
during the polymerisation process with the aid of a co-dopant which has a negatively
charged functional group [161]. Polypyrrole was electropolymerised with the
assistance of biotin to load nerve growth factor as a neural trigger. The
biocompatibility of Ppy suggests that it is possible to use these materials for
implantable drug delivery systems [52, 161].
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Table 1.2. Some of the significant works that utilised conducting polymer for controlled release of bio-active molecules.
Type of conducting
polymer
Ppy

Synthetic method

Structural form

Released components

Stimulation conditions

Reference

Electrochemical

Film on GCE

Glutamate (Glu)

[181]

Ppy

Electrochemical

Film on GM

Neurotrophin-3 (NT-3)

Ppy
Ppy
Ppy
Ppy
Ppy
PEDOT

Electrochemical
Electrochemical
Electrochemical
Electrochemical
Electrochemical
Electrochemical

Double layer film
Film
Film
Film
Film
Film on GE

Risperidone
Chlorpromazine (CPZ)
Nerve Growth Factor (NGF)
Tosylate, salicylate, nicoside, naproxen
Heparin
Dexamethasone

PEDOT

Electrochemical

Layer on Pt/Ir alloy

BDNF

CV
CV, pulsed potential &
Current
Pulse potential, CV
Pulse potential & QCM
Constant potential
Constant potential
Mechanical pressure
Pulse potential in
Passive, Better cochlear
Functionality with PEDOT
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[177]
[182]
[183]
[180]
[184]
[179]
[5]

1.4.2

Scaffolds for Cellular Interactions

Cellular studies performed on engineered extracellular matrix (ECM) scaffolds have
increased the understanding of cells interaction with tissue in the micro- and nanoscale domains [156]. Scaffolds as ECMs can be fabricated in a variety of
architectures such as printed layers [185], electrospun mats [3], wet-spun fibres [12],
however, important factors such as composition, dimension, mechanical properties
and flexibility may interfere with the cell interaction. This section will introduce
some successfully fabricated scaffolds with emphasis on their cellular interaction.
One method for the production of scaffolds is electrospinning which produces
connected 3D porous mats that exhibit a high surface area with ability to mimic
features of the ECM structure. Biocompatibility and biodegradability are the most
important necessities for electrospun nanofibres as a scaffold [131]. These properties
will determine the scaffolds’ ability to degrade within a timeframe in vivo and be
replaced with newly regenerated tissues [131]. Figure 1.12 compares cell interaction
between microfibres and nanofibres. Nanofibres have superior surface areas to
adsorb proteins, providing more binding sites to cell membrane receptors resulting in
improvement in cells attachment, proliferation and expression of matrix components
[186].
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Figure 1.12. A) Fluorescence graphs of confluent H9C2 myoblast cells on PLGA
nanofibres. B) Cell binding and spreading with respect to scaffold architecture. Cells
binding to microfibres flatten and spread. (Figure adapted from ref. [131] and [186]).

Mats which are prepared by the electrospinning method and employed as temporary
platforms for cells regeneration can be optimised in terms of thickness, morphology,
and structure by selection of right architectures. A high porosity and specific surface
area of an electrospun mat provides more cells attachment with multiple adhesion
points; as a result of its three-dimensional structure [187]. Moreover, because the
size of cells are approximately one magnitude larger than individual electrospun
fibres, cells are capable of attaching around the fibres and extend along its length
[188]. For instance, PLGA electrospun fibres were fabricated by Ko et al. to be used
as an human bone-marrow-derived mesenchymal stem cells (hMSCs) template and
showed cell attachment and proliferation on a PLGA electrospun mat [10]. Hsiao et
al. investigated the interaction of primary cardiomyocytes (CMs) with electrospun
PLGA fibres and showed that an aligned electrospun mat can direct cells for cardiac
tissue [3].
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In some cases, the scaffold is capable of enhancing the growth of attached cells with
electrical stimulation. For example, electrospun nanofibres of polyaniline (PANI)
with a mixture of polycaprolactone (PCL) and gelatin (G) were utilised to apply
electrical stimulation to nerve stem cells (NSCs) [189]. The results showed the
proliferation rate of cells was slightly higher in PCL and graphene nanofibres
without PANI whereas, the proliferation rate of cells on PCL-G electrospun fibres
with and without PANI was higher compared to tissue culture plate (TCP). They also
applied an electrical stimulation protocol with 1.5 V on cells for 15, 30 and 60 min.
The results demonstrated no significant cells proliferation for samples exposed to the
electrical field for 15 and 30 min, however, there was significant cells growth for
samples with 60 min electrical stimulation. Furthermore, they reported that the
average neurite length for NSCs grown on PANI/PCL/G with application of
electrical stimulation for 1 hr and without electrical stimulation was found to be
30 ± 1.1 and 22 ± 0.97 μm, respectively, indicating that the application of electrical
stimulus for 1 hr to NSCs cultured on PANI/PG significantly (p ≤ 0.05) enhanced the
neurite outgrowth. It is worth noting that the electrical stimulation did not show a
significant influence on neurite outgrowth for samples that were stimulated
electrically for 15 and 30 min [189].
Kam et al. reported cell growth on a single-walled carbon nanotube (SWCNT) and
laminin composite when electrical stimulation was applied [190]. The presence of
SWCNTs permitted the use of electrical stimulation of the neural stem cells (NSCs).
They indicated that 98% of cells on the surface of the SWCNT−laminin composite
were viable. The electrical stimulation of NSCs comprised a series (10−15) of 1 ms
pulses spaced at 1−10 s intervals. Ion-sensitive dyes undergo a change in
fluorescence intensity as a result of changes in ion concentrations upon application of
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an action potential. Confocal microscopy images of a cell cluster demonstrated a
clear increase in fluorescence dye (Fluo-4 a.m.) indicating an increase in population
of live cells after electrical stimulation [190].
The attachment of functional groups to a synthesised Ppy film has shown to be
advantageous for different biomedical and organic bioelectronic applications, such as
cell stimulation. This approach allows facile incorporation of bio-regulative cues to
provide a bio-mimicry and conductive environment for the promotion of cell
functionality [58]. For example, cell attachment on chlorine-doped polypyrrole
(Ppy.Cl) films has been improved by the immobilization of peptides (T59-GRGDS)
on the Ppy surface [191]. Relative cell attachment to Ppy.Cl film was analysed using
the rat pheochromocytoma cell line (PC12) as this cell line has been shown not to
adhere to Ppy.Cl in serum-free medium [191]. However, when the Ppy.Cl surface
was modified with the T59-GRGDS peptide, significant attachment was observed
[191]. Table 1.3 presents some of the significant biomedical applications of Ppy.
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Table 1.3. Some studies using Ppy in biomedical applications along with synthesis method and dopant used.
Synthesis method

Structure

Dopant

Application

Advantages

Electrochemical

Film on ITO glass

Cl

Promotion of
cells attachment

Chemical

Nanoparticles

SDS

Cells stimulation

Peptide immobilization on
Ppy.Cl
Conducting template with
PDLLA polymer

Electrochemical

Layer on micropatterns

pGlu*

Neurite guidance

Conducting micro-patterns

[193]

Chemical

Coating on
membrane

Chloride (from
Ferric chloride
oxidant)

Biosensor

Higher electrochemical stability
of PEDOT in longer term
applications

[68]

*pGlu = poly-l-glutamic acid
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Reference
[191]
[192]

Ppy doped with chondroitin sulfate (CS) has been electrochemically synthesised and
conjugated with type I collagen [58]. The collagen modification formed a 3dimensional fibrillar matrix at the surface of Ppy. However, no significant reduction
in the electroactivity of the fibrillar collagen-modified Ppy substrates was observed
[58]. The differentiation and neurite outgrowth of PC12 cells was improved due to
the collagen modification and electrical stimulation of the underlying Ppy substrate
(Figure 1.13).

Figure 1.13. Fluorescence micrographs of PC12 cells cultured on surface modified
Ppy at A) 2h, B) 24h, C) 144h and D) At 144 h after being subjected to electrical
stimulation applied with charge-balanced biphasic ± 1 mA current pulses with 100 µs
pulse width, 20 µs open-circuit interphase gap and 3.78 ms short-circuit phase
between pulses at 250 Hz. Scale bars represent100 µm. (Figure adapted from
Ref.[58].)
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Thompson et al. [194] showed elongation of neural explants from the rat pup cochlea
as a function of electrical stimulation. Neurite outgrowth from cochlea neural
explants grown on Ppy containing growth factors showed synergistic effect on both
neurotrophins. Neurite outgrowth was significantly improved when the polymers
containing growth factors (NT3 and BDNF) were electrically stimulated (Figure
1.14) [194].

Figure 1.14. Release of NT-3 and BDNF from Ppy films. A) With and B) without
electrical stimulation. A representative image of cochlea neural explants grown on
Ppy.pTS. C) Without electrical stimulation and B) with electrical stimulation (Figure
adapted from ref.[159]).

Vapour phase polymerised Ppy on poly (styrene-b-isobutylene-b-styrene) (SIBS)
electrospun fibres also exhibit potential in biomedical applications due to their ability
45

to align PC12. This alignment was facilitated by the aligned patterns of the
electrospun material as well as the application of electrical stimulation [195, 196].
Highly aligned PC12 neurite outgrowth was achieved by applying electrical
stimulation to aligned electroactive Ppy coated SIBS nanofibres (Figure 1.15) [195].

Figure 1.15. A and B) Fluorescence images of PC12 cells on aligned Ppy/SIBS
electrospun fibres. The F-actin filaments in PC12 cell bodies and neurite outgrowths
are shown by arrows in A. C) Fluorescence images of PC12 cells on Ppy films
without Ppy/SIBS fibres. Scale bars represent 10 µm (Figure adapted from
Ref.[195]).

PEDOT film was shown to be capable of controlling cell density gradient which in
turn influenced cells interaction with their neighbour environment [70]. A poly(3,4ethylenedioxythiophene) doped with p-toluenesulfonate (PEDOT-TOS) film,
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exhibiting a redox gradient, was deposited by vapour phase polymerization onto
indium tin oxide (ITO) with varying thicknesses [70]. Varying the polymer film
thickness resulted in a gradient density of normal and cancerous cells, their
attachment and proliferation. Moreover, Abidian et al. deposited PEDOT using
lithium perchlorate as the dopant on the surface of platinum (Pt/Ir) electrode to
enhance the electroactive surface area of neural electrodes, and reported a lower
impedance for the modified neural electrode compared with a traditional metal
electrode [197]. Table 1.4 demonstrates some examples of the role PEDOT in
biomedical applications.
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Table 1.4. Some of studies using PEDOT in biomedical applications along with synthesis method and dopant used.
Synthesis

Structure

Dopant

Application
Neural
recording

Electrochemical

Coated on neural
probes

Chemical

Coating on
membrane

Ferric chloride

Biosensor

Electrochemical

Coating on
neural probe

Lithium
perchlorate, TEAP

Neural
recording

Electrochemical

Coating on
tissue culture
plate

Tosylate

Cells host
template

Electrochemical

Film

Heparin

Stem cells
templates

Vapour phase

Film on ITO

p-Toluenesulfonate
(PTS)

Cells template

PSS
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Advantages
Peptide
incorporation on
probe
Higher
electrochemical
stability of PEDOT
in longer term
applications
Lowering
impedance and
ability to control
release of
dexamethasone
Electrically
controlling cells
attachment
Electrochemically
controlling the stem
cells
Microenvironment
Controlling cells
gradient

Reference
[69]

[68]

[179, 198]

[67]

[199]
[70]

The use of graphene and graphene oxide without any polymer or additives to produce
composites for biomedical applications is relatively new, with only limited number
of publications reporting their use. However, their use to form composites containing
biocompatible and biodegradable polymers is becoming more widely studied [200,
201]. These composites are mostly utilised as scaffolds for tissue engineering [200,
201]. For instance, a group of researchers in the University of Louisiana investigated
cellular interaction with a composite of graphene oxide-chitosan [14]. They showed
that pre-osteoblasts could attach and proliferate well on the surface and inside of
chitosan pores and it presented these composites as potential scaffolds for bone
regeneration due to the fact that graphene oxide enhanced the mechanical properties
of the composite [14]. In addition, these scaffolds containing graphene oxide had a
lower rate of enzymatic degradation compared with a pure chitosan scaffold, due to
reaction between amine groups of chitosan with hydroxyl groups of graphene oxide
[14]. Other work introduced graphene oxide (GO) as filler for the enhancement of
mechanical properties, and as a template for biological attachment in a gelatin-GO
film [113]. Li et al. reported preparation of graphene papers made from highly
ordered graphene sheets with the biocompatibility of these papers proven using L929 (mouse fibroblast) cells (Figure 1.16) [202].
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Figure 1.16. Fluorrescence microscopy
m
iimage of Calcein
C
AM
M stained L
L-929 cells
g
ox
xide paper ((Figure adap
pted from Ref.
R [202]).
grown oon reduced graphene

Graphenne and its derivatives
d
are
a increasinngly having
g an impact as organic cconductors
in tissuue engineeering to convert
c
nonn-conductin
ng biocompatible poolymers to
conductting compoosites. Thesse conductiing compossites may be
b used too modulate
cellular activity thrrough electrrical stimulaation of cellls.
Heo et al. reportedd the use off a composiite of polyeethylene terrephthalate (PET) and
graphenne to controol SHSY5Y
Y human nneuroblastom
ma cell-to-cell interacction using
electricaal stimulattion. They utilised charge-balaanced biph
hasic pulsees with a
frequenncy of 1 Hzz for a totaal time periiod of 32 min
m to geneerate an eleectric field
ranging from ±4.5 mV/mm to
o ±450 mV
V/mm. They
y imaged ceells every 550 seconds
using flluorescent microscopy
m
y and show
wed that thee graphene-PET compoosite films
had no toxicity for
f SHSY5Y human neuroblasto
oma cells and that tthe largest
w observved at the ±450 mV/mm
m electric ffield while,
percentaage of shruunken cells was
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the smallest percentage of shrunken cells was observed at the 4.5 mV/mm electric
field. Hartig et al. investigated the effect of electrical field on proliferation rate of
osteoblast-like primary cells and found that an external voltage signal with electric
field of 6kV/m can enhance proliferation, maturation and ECM protein synthesis of
osteoblast in vitro [203]. Ahadian et al. showed that protein expression profoundly
increases by applying electrical stimulation on C2C12 myotubes using an integrated
methacrylated gelatin (GelMA) hydrogel with aligned carbon nanotubes as a
conducting platform [204]. They reported myosin heavy chain protein was
significantly found after electrical stimulation that performed on the day 8th of cell
culture experiments for two consecutive days [204]. Researchers in National
University of Singapore showed that the cells proliferation and expression of CX43
were improved after applying electrical stimulation. It is worth to note that CX43 is a
cardiac-muscle-specific intermediate lament protein which has an important role in
cardiac contractility [205].
In conclusion, the overall aim of this thesis is to develop a range of fibrous 3D
architectures of composite biomaterials. These composites were prepared from
conducting and non-conducting materials and were evaluated for their suitability and
use in drug delivery and support of cellular growth.
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2 FABRICATION OF MULTIFUNCTIONAL
CONDUCTING POYMERIC FIBRES AND
THEIR POSSIBLE APPLICATION IN
CONTROLLED RELEASE OF DRUG

The results of this chapter have been published as a full paper in the Journal of
Controlled Release:
Esrafilzadeh D, Razal M. J., Moulton E. S., Stewart M. E., Wallace G. G.,
“Multifunctional conducting fibres with electrically controlled release of
ciprofloxacin”, Journal of Controlled Release, Vol. 169, No.3, pp. 313–320, 2013.
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2.1 Introduction
The fabrication of conducting biomaterials for different applications such as
neuroprosthetic electrode has been investigated [1, 2]. This kind of electrode is
capable of electrical stimulation of cells as well as recording cells signals. The
electrode can be fabricated in the form of different architectures and geometry
including pads, cuffs or longitudinal intra-fascicular electrodes [1, 3-5].

Some of the critical factors for the application of these structures in vivo include their
biocompatibility, stable conductivity, low impedance, appropriate mechanical
properties and flexibility [3]. The risk of infection and inflammatory complication
after electrode implantation [4] raised the idea of incorporating anti-inflammatory or
antibiotic drugs during bio-electrode development [6].

There is a wide range of drug delivery formulations such as polymeric structures that
are capable of responding to external stimuli including thermal transition [7, 8], pH
[9, 10] or electrical stimuli [11], and result in holding or releasing of biological
components. Controlled drug release by electrical stimulation is becoming an
attractive option in the treatment of acute disease or chronic illness as it has the
ability to tune the release profile based on the stimulation conditions employed [12,
13].

Inherently conducting polymers (ICPs) are a type of organic conductors that has been
investigated for use in conducting bio-structures. ICPs in conjunction with
biopolymers simultaneously introduce conductivity and biocompatibility into
bioelectrodes. These structures are capable of recording neural cells activity [14] as
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well as responding to electrical stimulation to release therapeutic components [15,
16]. One of the advantages of conducting polymers in comparison to metals as a
substrate for biomedical applications is their lower electrochemical impedance [2].
This helps to hold or release appropriately sized biomolecule/drug, which leads to
controlled release via electrical stimulation with higher efficiency. Previously,
controlled release of dexamethasone (DEX) has been carried out using Poly (3,4ethylenedioxythiophene) PEDOT and applied for neural recording [17]. In addition,
the release of the neurotrophin NT-3 from a polypyrrole film has been reported by
Wallace et al. [18-20]. The incorporation and release of different types of antibiotics
and anti-inflammatory drugs such as penicillin, streptomycin and dexamethasone
have also been applied to polypyrrole matrixes [21]. The incorporation of ICPs in
biopolymers has currently been limited to 2-dimensional films either in metal
supported or coated films. Moreover, some drawbacks relating to applications of
ICPs films include their brittleness, firmness, need for structural support and
competent charge carrier (i.e. gold mylar), and their delamination from the support
substrate during redox processes. Each of these parameters could influence the
quality of films during drug delivery processes [5, 22].

Efforts for the fabrication of ICPs in 3-dimensional structures have been performed
to introduce more flexibility as well as self-support capabilities for the structures
[22]. Among different fabrication methods, wet-spinning is one method capable of
producing 3-dimensional, flexible architectures for bionic applications. Recently,
highly conducting PEDOT:PSS fibres produced by a wet-spinning method have been
shown to possess stable electrochemical properties [23]. Doped polypyrrole has also
been fabricated by a wet-spinning method into conducting micro-scale fibres with
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appropriate electrochemical and mechanical properties [24]. To the best of our
knowledge, ICP micro-scale fibres have not previously been applied for drug
delivery systems.

This chapter presents a novel method to produce coaxial ICP fibres wherein
electrically controlled release of the antibiotic ciprofloxacin hydrochloride is
achievable. Firstly, PEDOT:PSS-chitosan hybrid fibres were fabricated employing
an ionic complexation fibre spinning strategy involving the coagulation of
PEDOT:PSS using chitosan as the coagulant. Ciprofloxacin hydrochloride (antibiotic
drug) was selected as a drug model. The hybrid fibre was subsequently used as a
working electrode for the electropolymerisation of a ciprofloxacin hydrochloride
doped Ppy layer (Ppy.Cipro). The PEDOT:PSS-chitosan acts as structural support
and electronic conductor to electrochemically switch the Ppy.Cipro layer between
reduced and oxidised states to controllably release (or retain) Cipro. The bioactivity
of wet-spun fibres and the released antibiotic drug (Cipro) were evaluated in vitro.
Furthermore, the cytotoxicity of the fibres and their components was tested against
B35 neuroblastoma cell lines.
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2.2 Experimental
2.2.1 Wet-spinning of PEDOT:PSS-CHI fibres
Poly (3,4-ethylenedioxythiophene) poly(styrene sulfonate) (PEDOT:PSS) pellets
were obtained from Agfa (Orgacon dry, Lot A6 0000 AC). A spinning solution of 25
mg/ml in water was prepared by dispersing the required amount of PEDOT:PSS
pellets in water followed by homogenizing at 10,000 rpm for 10 min [23].
PEDOT:PSS dispersion was loaded into a syringe with a detachable needle (20
gauge) as the spinneret. The feeding ratio applied for wet-spinning was 15 ml/hr
using a syringe pump (KDS-Scientific 100). A concentration of 1.0 wt. % chitosan
(CHI) was dissolved in 2.0 wt. % acetic acid to prepare the coagulation bath. In order
to perform wet-spinning, PEDOT:PSS was injected into the chitosan coagulation
bath to form gel-state fibres as a result of ionic cross-linking between chitosan and
PSS. Then fibres were passed through an ethanol-washing bath before collecting on a
spool. Oven dried PEDOT:PSS-CHI fibres were post-treated via ethylene glycol
(EG) followed by heat treatment in 120 °C for 30 min to enhance fibre conductivity
[25].
2.2.2 Electrical and electrochemical characterisations
The electrochemical properties of PEDOT:PSS-CHI, PEDOT:PSS-CHI-Ppy.Cipro
films (control) and fibres have been investigated using cyclic voltammetry (CV) and
electrochemical impedance spectroscopy (EIS). The conductivity of fibres was
measured using a linear four-point probe conductivity cell with uniform 2.3 mm
spacing between probes. A galvanostat current source (Princeton Applied research
Model ED402) and digital multimeter (HP Agilent 34401A) were used to obtain the
conductivity (under laboratory humidity and temperature conditions).
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Cyclic voltammetry of the fibres was performed in a 3-electrode cell, using a
potentiostat source (Princeton Applied research Model ED402) with EChem version
1.5 software. The electrochemical impedance spectroscopy (EIS) was carried out in a
two-electrode cell in phosphate buffered saline (PBS) electrolyte using a Gamry
Instruments Framework (V.5.5).
2.2.3 Scanning electron microscopy
Physical characterisations of the fibres were performed using scanning electron
microscopy (FESEM) (JEOL JSM-7500FA). Samples for cross-section imaging were
prepared by breaking a frozen fibre, after dipping into liquid nitrogen, to observe
fibre morphology. The chemical elements present in the surface and cross-section of
PEDOT:PSS-CHI and PEDOT:PSS-CHI-Ppy.Cipro fibres were investigated using
energy-dispersive x-ray spectroscopy (EDX), and the presence of sulphur
(PEDOT:PSS) was traced to determine the component of fibres.
2.2.4 Elemental analysis of fibres
In order to determine the mass ratio between PEDOT:PSS and chitosan in the fibres,
elemental analysis for nitrogen (N) and sulphur (S) was performed using an
automatic analyser (Carlo Erba 1106) technique at the Australian National University
(ANU, Canberra). In this case, four different samples were examined including dry
PEDOT:PSS powder, dry chitosan powder, a PEDOT:PSS-CHI film prepared by
blending solutions of PEDOT:PSS with chitosan (1.0 wt. %) at a ratio of 9:1, and
PEDOT:PSS-CHI fibres.
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2.2.5 Synthesis of Ppy.Cipro layer on the surface of PEDOT:PSS-CHI fibres
The synthesis of Ppy.Cipro was performed galvanostatically in a glass vial using a
platinum mesh (counter electrode), an Ag/AgCl reference electrode and a goldcoated substrate as the working electrode [26]. The polymerisation solution
contained 0.2 M pyrrole monomer and 50 mM ciprofloxacin hydrochloride as a
dopant that was selected according to the previous monomer and dopant selection
carried out in our group [18-20]. A potentiostat (Princeton Applied research Model
ED 402) with EChem version 1.5 software was utilised for electropolymerisation. All
current densities were normalised by geometric surface area of the working
electrode. All films grown on gold mylar were washed in Milli-Q water for 5 min
after electropolymerisation to remove any unincorporated dopant on the surface of
fibres.
Different current densities (0.5, 1.0 and 2.0 mA/cm2) and polymerisation times (30
sec, 10 and 20 min) were utilised for Ppy.Cipro growth.
2.2.6 Mechanical property testing
The tensile properties of the fibres were measured using a Shimadzu EZ-S tensile
tester at a strain rate of 0.5 %/min. Samples were mounted on aperture cards (1.0 cm
length window) with commercial super glue and allowed to air dry. Young's
modulus, tensile strength and breaking strain were obtained and the mean and
standard deviation calculated for n = 10.
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2.2.7 In vitro ciprofloxacin release study
The profile of ciprofloxacin release from wet-spun fibres was determined by
collection of Cipro aliquots in PBS at different time points (0-72 hr) in different
redox states (reduced, passive & oxidised) of the Ppy.Cipro layer using a 3-electrode
cell set-up. Ciprofloxacin is an antibiotic from fluoroquinolone class that are
effective against broad range of bacteria (gram-negative and gram-positive). It is not
electroactive in the range of potential that electrical stimulation applies in our
experiments set-up for controlled drug release. It is negatively charge in aqueous
solution and performs as a counter ion over electrochemically polymerisation of Ppy.
The release medium was collected by micropipette at specific time points and
replaced with the same volume of fresh PBS solution. To be able to calculate the
percentage of released drug, known concentrations of Cipro in PBS (0.01 µg/ml to 8
mg/ml) were prepared and the absorbance of Cipro at its max 270 nm (by UV.Vis
spectroscopy) was used to form a calibration curve. The UV-Vis spectra of PBS
solutions were recorded between 200 nm and 300 nm using a Shimadzu UV 1601
spectrophotometer in order to construct the absorbance/concentration calibration
curve. The release potential conditions were selected according to the cyclic
voltammogram of the PEDOT:PSS-CHI-Ppy.Cipro fibre (Figure 2.9). In order to
reduce and oxidise the conducting polymer (Ppy), constant potentials of -0.26 V and
+0.3 V were used, respectively.
The loading efficiency of Cipro per 1.0 cm length of fibre was estimated by
dissolving 1 cm length of fibre in PBS solution. The drug loaded fibre was bath
sonicated for 5 days until the fibre completely dissolved and the Ppy.Cipro coating
broke down, then the solution was filtered and the Cipro concentration was obtained
by UV-Vis spectroscopy. To monitor the effect of sonication on the absorption
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properties of Cipro, control solutions of known concentrations of Cipro in PBS were
treated under the same conditions as the fibres. All cumulative Cipro release data are
plotted as a percentage of (Mt) release relative to the Cipro loading (Mtot). Cipro
release was investigated under passive diffusion and electrical stimulation conditions
in two different patterns. In the first one, constant potential (reduced or oxidised) was
applied to fibres during 72 hr whilst, in the second pattern, an alternating potential
was applied by switching between reduced and oxidised potentials every 24 hr for 72
hr. For electrically stimulated release, a platinum mesh and Ag/AgCl electrode were
utilised as the counter electrode and the reference electrode, respectively, while the
PEDOT:PSS-CHI-Ppy.Cipro fibre was the working electrode. The release solution
was gently stirred at constant speed (50 rpm) during the release experiments to assist
diffusion of Cipro from the surface of the fibres. Fibres with consistent lengths (1 cm
in PBS) and thicknesses (diameter of PEDOT:PSS-CHI fibres was 65 ± 7 µm with
1.3± 0.3 µm thickness of Ppy.Cipro layer) were selected for testing.

2.2.8 Antibacterial activity of released ciprofloxacin
The activity of the Ciprofloxacin hydrochloride released from the fibres was tested
against both Gram-negative Escherichia coli (JM109) and Gram-positive
Streptococcus pyogenes (NS5448). Bacterial lawns were prepared by firstly
inoculating 5 ml of Luria-Bertani (LB) medium or Todd Hewitt (TH) broth with E.
coli or S. pyogenes respectively for overnight incubation at 37 °C. This culture was
then used to inoculate a 10 ml culture, which was grown to mid-log phase (OD600
0.6-0.8; determined using an Ultrospec10 spectrophotometer). This culture was then
diluted 1/5 in sterile 0.9 % (w/v) NaCl in Milli-Q, and 200 μl of this suspension was
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spread onto LB or TH agar plates. The bacterial suspension was air dried prior to
application of either fibres or discs.
Following fibre production, dried fibres were prepared in 1.0 cm lengths for
antibacterial testing. To test the efficacy of Cipro released from fibres, lengths were
carefully placed onto the surface of the prepared plates which were then inverted and
incubated at 37 °C overnight prior to examination. Both PEDOT:PSS-CHI and
PEDOT:PSS-CHI-Ppy.Cl fibres were tested as controls to ensure no antibacterial
activity was exhibited by other components of the fibres. The bioactivity of Cipro
released from the fibres either passively or under electrical stimulation was also
tested. The fibres were placed in 500 μL PBS for 72 hr. Release samples were then
loaded onto sterile 6 mm discs of Whatman No.1 filter paper and allowed to air dry
at room temperature. The loaded discs were then carefully placed onto prepared
bacterial plates. Discs placed on E. coli lawns were loaded with 10 μl of release
media, and discs placed on S. pyogenes lawns were loaded with 20 μl of release
media to account for the different susceptibilities of the bacterial strains to Cipro.
Control discs were also prepared by preloading with 1 μg of ciprofloxacin
hydrochloride for efficacy comparisons.

2.2.9 Cytotoxicity testing
The cytotoxicity of PEDOT:PSS-CHI, PEDOT:PSS-CHI-Ppy.Cl and PEDOT:PSSCHI-Ppy.Cipro fibres were tested against a B35 neuroblastoma cell line (ATCC) as
an available neural cell line in our laboratory. Cells were cultured in DMEM medium
supplemented with 10 % (v/v) fetal bovine serum (FBS, Invitrogen). The fibres were
aligned on glass slide substrates and an 8-well cell culture chamber was glued onto
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the substrate to immobilise the fibres at the substrate surface. The fibre surfaces were
sterilised by rinsing in 70 % (v/v) ethanol followed by air-drying. The fibres in each
well were coated with Type IV rat tail collagen by exposing the surface to 50 μg/ml
collagen prepared in 0.02 % acetic acid solution for 1 hr at room temperature. Each
well was then rinsed twice in serum free medium prior to cell seeding at a density of
10,000 cells/cm2. Cells were incubated at 37 °C in a humidified 5 % CO2
environment for 72 hr prior to staining and imaging. Cells were stained for metabolic
activity by the addition of Calcein AM (Invitrogen) to a final concentration of 1
µg/ml in cell culture media, followed by incubation as above for 15 min. Propidium
iodide (Invitrogen) was then added to a final concentration of 1 µg/ml and the cells
incubated for 5.0 min at room temperature. The medium was then gently removed
and replaced with fresh PBS prior to imaging with an AxioImager fitted with a Mrm
AxioCam, and images were overlayed using AxioVision Software (Zeiss). An LDH
release assay was also performed to determine the IC50 for Cipro against B35 cells.
B35 cells were seeded at a density of 5,000 cells/well into a 96 well plate. Following
24 hr incubation as described above, cell media were replaced with complete media
containing a dilution series of Cipro starting at the highest concentration of 1.0
mg/ml. Following 48 hr incubation, cell media were collected and assayed for LDH
activity using the CytoTox 96® Non-Radioactive Cytotoxicity Assay (Promega).
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2.3 Results and discussion
2.3.1 Wet-spinning of PEDOT:PSS-Chitosan
Polyionic complexation coagulation strategy was utilised to wet-spin PEDOT:PSS
fibres. PEDOT:PSS dispersion (25 mg/ml) was injected into a chitosan (CHI)
coagulation bath. Based on the polyionic complexation coagulation strategy [27], the
“free” negatively charged polystyrene sulphonate acid (PSS) groups of PEDOT:PSS
react with the positively charged amino groups of chitosan to form a gel fibre.
Different concentrations of CHI (from 0.5 to 2.0 wt. %) were tested as the
coagulation bath. Table 2.1 shows the spinnability of the PEDOT:PSS dispersion as a
function of chitosan coagulation bath concentrations. Results showed that
PEDOT:PSS fibres could not be coagulated at CHI concentrations of less than 1.0
wt. %. The spinability of PEDOT:PSS fibres was improved significantly by
increasing the concentration of CHI to 1.0 wt. %. However, as the concentration of
CHI increased, increase in viscosity made the spinning harder until the concentration
of 2.0 wt. %, which prevented the spinning of PEDOT:PSS fibres. Therefore, the
minimum CHI concentration (1.0 wt. %) needed for effective spinning was chosen as
the coagulation bath. This also can minimise the uptake of CHI (an insulator) via
PEDOT:PSS during the coagulation process which may have less adverse effect on
the conductivity of the resultant fibres.
Table 2.1. Comparision on spinability with respect to the concentration of the
coagulation solution.
Chitosan conc.
(wt.%)
0.5
1.0
2.0

Feeding rate
(ml/hr)
25
25
25
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Spinability
No
Yes
Yes

Following coagulation, the fibres were passed through an ethanol bath to remove
excess chitosan, which remained un-reacted and only stuck on the surface of the
fibres (Figure 2.1). This washing process was critical since the unreacted chitosan
can form an insulating layer around the fibre, which is detrimental for both electrical
and electrochemical properties of the final fibres. It is worth mentioning that, in
contrast with solvent/non-solvent prepared PEDOT:PSS fibres [23], PEDOT:PSSCHI fibres are insoluble and stable in aqueous media (pH ⋍ 7.4) due to the presence
of insoluble chitosan in pH ⋍ 7.4 and polyionic complexation between positively
charged chitosan and negatively charge PSS.

Figure 2.1. Schematic picture of wet-spinning process of PEDOT:PSS-CHI fibre.

2.3.2 Physical characterisation of PEDOT:PSS-CHI fibres
SEM micrographs of a representative PEDOT:PSS-CHI fibre and its cross-section
are shown in Figure 2.2. The PEDOT:PSS-CHI fibre was dense and non-porous with
a smooth surface and a circular cross-section (diameter = 65 ± 7 µm) upon drying
under tension.
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Figure 2.2. A) SEM images of PEDOT:PSS-CHI fibre, B) cross-section of fibre.

The scalability of this wet-spinning method was confirmed by spinning of continuous
and long lengths of fibres. It is worth noting that PEDOT:PSS fibres which were
spun by utilising solvent/non-solvent strategy (i.e. acetone or isopropanol) are
soluble in PBS, the fluid which mimics the physiological body fluid in our in vitro
tests [25]. However, the stability of chitosan in pH ⋍ 7.4 and the crosslink reaction
between PSS and chitosan provide enough stability of PEDOT:PSS-CHI fibres in
PBS which facilitates the following drug delivery and cell culture experiments.

The elemental composition of the fibres was evaluated using energy-dispersive X-ray
(EDX) spectroscopy. The EDX spectrum showed sulphur peaks which confirmed the
presence of PEDOT:PSS on the surface of the fibre. However, the cross-sectional
EDX suggests a hybrid structure of PEDOT:PSS-CHI fibre (Figure 2.3).
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Figure 2.3. A) Scanning electron microscopy (SEM) images of the cross-section of
PEDOT:PSS-CHI fibres. i, ii and iii) Energy-dispersive X-ray (EDX) spectrum
recorded from the cross-section of PEDOT:PSS-CHI fibre.

Figure 2.3 shows sulphur peaks for all the three different selected spots on the cross
section of the fibres. The results show sulphur peaks in both the surface and crosssection of the fibres, which suggests that PEDOT:PSS was present in all of the
fibre’s regions. In addition, the presence of sulphur on the surface of fibres (presence
of PEDOT:PSS) provided surface conductivity. The surface conductivity of fibres is
crucial to be utilised as a working electrode in a 3-electrode cell.

Elemental analysis was carried out to determine the overall percentages of
PEDOT:PSS and chitosan in the dried fibre (base on the sulphur (S) and nitrogen
content (N)). Table 2.2 shows the elemental analysis of different compositions of
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PEDOT:PSS-CHI film and fibres and the calculated percentages of N and S. In order
to calculate the percentage of PEDOT:PSS in the dried fibres, first the percentage of
N and S that solely existed in CHI and PEDOT:PSS respectively were measured for
control samples. Then, a known composition of both components was produced
(90:10) and the amount of both S and N in this known composition determined.
Finally, based on the percentage of nitrogen from chitosan and sulphur from
PEDOT:PSS in the control samples (Table 2.2), a calibration curve was provided and
was used to determine the ratio of chitosan to PEDOT:PSS in the fibres. The
composition was calculated to be 3.2% to 96.7%, respectively. Such a low mass ratio
of chitosan in the fibres is favourable as it would have a lower negative impact on the
electrical conductivity of the hybrid fibre. The percentage of chitosan in the fibres is
critical, as a lower amount of chitosan does not coagulate PEDOT:PSS and a higher
proportion can adversely affect the conductivity.
Although, the spinning of fibres is the first step in the fabrication of 3-dimensional
structures, the electrical and electrochemical properties of the as-spun fibres are
much more important as the goal of using organic conductors is to utilise these
properties in 3-dimensional architectures.
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Table 2.2. Elemental analysis results of PEDOT:PSS-CHI fibres on the basis of
nitrogen (N) and sulphur (S).
Sample

N%

S%

Chitosan Sheet

5.9±0.0

0.0±0.0

PEDOT:PSS Powder

0.0±0.0 16.1±0.5

PEDOT:PSS-CHI Sheet Ratio (90:10) 0.8±0.0 13.8±0.1
PEDOT:PSS-CHI fibre

3.2±0.0 96.7±0.0

2.3.3 Electrochemical characterisation of PEDOT:PSS-CHI fibres
The electrochemical behaviour of the fibres was investigated through cyclic
voltammetry (CV) using PEDOT:PSS-CHI hybrid fibres as the working electrode in
PBS buffer (Figure 2.4). In order to improve the electrical and electrochemical
properties of the fibres, ethylene glycol (EG) treatment was carried out (see
experimental section for more details). The conductivity of EG-treated fibres
measured by the four-point probe method was 56 ± 7 S/cm. EG-treated fibres also
exhibited well-defined electrochemical responses corresponding to oxidation (-0.3 V)
and reduction (-0.5 V) of the PEDOT backbone (Figure 2.4). The improved
electrochemistry after EG treatment is attributed to a change in the conducting
polymer conformation from a compact coil to an extended coil configuration
followed by phase separation between excess PSS and PEDOT [23].
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Figure 2.4. Cyclic voltammograms of PEDOT:PSS-CHI fibre in PBS (pH ~ 7.4)
between -1.0 V and +0.8 V at scan rate of 50 mV/s (B). Arrows indicate the direction
of potential scan.

The electrical and electrochemical properties of the EG-treated PEDOT:PSS-CHI
fibres demonstrated high electrical conductivity and stable electrochemistry in
aqueous media. Therefore, this fibre was chosen as a micro-dimensional electrode
onto which a drug loaded polypyrrole (Ppy) conducting polymer was
electrochemically polymerised.

Additionally,

the

stability

of

electrochemical

performance

of

EG-treated

PEDOT:PSS-CHI fibres is evidenced by negligible electrochemical changes after
100 cycles in PBS (Figure 2.5).
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Figure 2.4. Cyclic voltammogram of PEDOT:PSS-CHI fibres before and after 100
cycles in PBS. The CV was performed in PBS (pH ~ 7.4) between -1.0 V and +0.8 V
at a scan rate of 50 mV/s (B). Arrows indicate the direction of potential scan.

2.3.4 Electropolymerisation of Ppy.Cipro layer on PEDOT:PSS-CHI fibres
The drug selected was ciprofloxacin hydrochloride (Cipro) (Figure 2.5), a synthetic
antibiotic of the fluoroquinolone drug class that covers a broad range of bacteria
(Gram negative and Gram positive) [28].

84

Figure 2.5. Chemical structure of ciprofloxacin hydrochloride.

There are several possible methods to incorporate drugs into the fibres. One way is to
mix the drug with the PEDOT:PSS spinning solution. The other way is to add the
drug via electropolymerisation of another layer of conducting polymer on the surface
of fibres. The first method is facile, however the drug can be discharged inside the
coagulation bath during wet-spinning resulting in negligible drug loading. However,
the second method, which has been used to incorporate different molecules such as
dyes or biological molecules such as drugs, growth factors, enzymes into the
conducting polymer backbone [19, 29], does not lose the drug during the fabrication
process. Therefore, ciprofloxacin incorporation using the polymerisation method was
investigated. Polypyrrole (Ppy) is one of the conducting polymers which has been
utilised for different biomedical applications including drug delivery. Vapour phase,
chemical and electropolymerisation are different methods for Ppy synthesis, which
have been introduced in Chapter 1 in detail. Electropolymerisation is a common
synthesis procedure that has been used for more than a decade. Depending on the
parameters selected for polymerisation, such as monomer and dopant concentrations,
current density and time of polymerisation, the quality of the Ppy layer can be varied
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from thin and bulky to thick and uniform layer. The polymerisation conditions
applied in this work are based on previous research performed by Thompson et al. in
our group [19].

Figure 2.6. A) SEM images of PEDOT:PSS-CHI fibre after electropolymerisation of
the Ppy.Cipro second layer (arrows show polymerised (black) and uncoated (white)
ends). B) Cross-section of Ppy.Cipro end (the white dashed line is included to aid the
reader in observing the Ppy.Cipro layer). The current density used to polymerise the
Ppy.Cipro layer was 2 mA/cm2 and the polymerisation time was 10 min.

The electropolymerisation was performed in a 3-electrode cell using PEDOT:PSSCHI fibres as working electrode. By applying electric forces from an external
potential source, pyrrole monomer was radicalised and initiated dimer and oligomer
synthesis [29]. Over time, the oligomer chains grow longer and eventually polymer is
synthesised. The difference in physical morphology of PEDOT:PSS-CHI fibre with
and without Ppy.Cipro layer is clear in Figure 2.6-A. The black arrow indicates the
end of the fibre which was exposed to the polymerisation solution, while the white
arrow indicates another end of the fibre which was not immersed in the
polymerisation solution. Figure 2.6-B illustrates the cross-section of PEDOT:PSS86

CHI-Ppy.Cipro that clearly shows the layer of Ppy.Cipro on the PEDOT:PSS-CHI
fibre. Additionally, the presence of the Ppy layer on the fibres was confirmed by
Raman spectra in the following sections.

Figure 2.7. SEM images of PEDOT:PSS-CHI-Ppy.cipro prepared at different times
of polymerisation. A and B) polymerisation time: 20 min, current density: 2.0
mA/cm2. C and D) polymerisation time: 30 sec, current density: 2.0 mA/cm2. B and
D images are the cross-sections of A and C images respectively.

It was demonstrated that as current density and time of polymerisation increases, the
thickness of Ppy.Cipro layer rises (Figure 2.7). This can be useful in alteration of
drug loading in Ppy.Cipro layer. The polymerisation potentials (~ +0.2 to +0.5)
observed were lower than potentials (+0.9 to +1.2) commonly observed for Ppy;
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showing a safer region against overoxidation of polymer and synthesis of nonconducting layer eventually. Table 2.3 shows thicknesses of Ppy.Cipro layers and the
oxidation potentials of polymerisation, obtained using SEM images and EDAQ data
respectively, as functions of current density and polymerisation time. As the current
density decreased the oxidation potential decreased and the thickness of the
Ppy.Cipro decreased in a given polymerisation duration. It was also possible to
increase the thickness of the Ppy.Cipro layer by increasing the polymerisation
duration. However, the current density of 2.0 mA/cm2 and polymerisation time of 10
min were used in this study and provided sufficient thickness of the polymer layer.

Table 2.3. Oxidation potential and thickness of Ppy.Cipro layer as a function of
polymerisation conditions. The thickness was determined using SEM images.
Current

Polymerisation

Thickness of Ppy.Cipro

Oxidation

density

time

layer

potential

(mA/cm )

(min)

(µm)

(V)

2.0

20

1.9± 0.1

0.45

2.0

10

1.3± 0.3

0.45

2.0

0.5

NA

0.45

0.5

20

1.4± 0.1

0.33

0.5

10

0.5± 0.1

0.28

0.5

0.5

NA

0.28

2

2.3.5 Physical and electrochemical characterisations of PEDOT:PSS-CHI-Ppy.Cipro
fibres
In order to confirm the presence of Ppy.Cipro on the surface of PEDOT:PSS-CHI
fibres, Raman spectroscopy of fibres was carried out. The Raman characteristics of
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PEDOT:PSS-CHI fibres with/out Ppy.Cipro layer were studied (Figure 2.8). For the
PEDOT:PSS-CHI fibre, peaks were observed at 1530 1/cm (C=C stretching), 1426
1/cm (C=C stretching), 1366 1/cm (C-C stretching) and 1257 1/cm (C=C stretching)
with these assignments based on reports by others [23]. The spectra of the
PEDOT:PSS-CHI-Ppy.Cipro fibre and Ppy.Cipro film (control) presented strong
sharp peaks in 1580 1/cm (C=C stretching), a double peak at 1320 and 1380 1/cm
(ring stretching) and peaks at 927 and 1240 1/cm (C-H out of plane bending)
indicative of the oxidised form of Ppy [29].

Figure 2.8. Raman spectra of Ppy.Cipro grown on PEDOT:PSS-CHI fibre.

Transformation of the Raman vibration properties from PEDOT:PSS to Ppy after
electropolymerisation of the second layer confirms formation of the Ppy layer on the
fibre substrate. However, changes in Raman spectra depend on the thickness of the
Ppy layer and time of polymerisation since, after polymerisation of longer than
10 min, the Ppy.Cipro layer was thick enough to avoid penetration of the Raman
laser into the PEDOT:PSS-CHI layer.
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The electrochemical properties of the fibres are crucial when, the aim of the fibres
fabrication is for application in the control of drug release via electrical stimulation.
Electrochemical testing by CV of the PEDOT:PSS-CHI fibres (Figure 2.9-A) showed
oxidation and reduction peaks at -0.3 V and -0.5 V, respectively. Upon Ppy.Cipro
polymerisation, the oxidation and reduction peaks shifted to +0.2V (oxidation) and 0.1V (reduction) when a thick Ppy.Cipro layer was achieved (i.e. thickness of
Ppy.Cipro: 1.3± 0.3 µm and polymerisation time: 10 min). This redox behaviour was
similar to that of a Ppy.Cipro film grown on gold mylar in PBS [19], suggesting
these redox peaks were due to the Ppy.Cipro polymer. The redox values are at
potentials higher than the oxidation state of the PEDOT:PSS fibre core (-0.2V). This
provides the possibility to switch between oxidised and reduced states for the
Ppy.Cipro layer whilst, the PEDOT:PSS layer remains in its oxidised state
(conducting state). This is very important as the PEDOT:PSS core can act as a
conduit for charge delivery during different redox states of the drug loaded
Ppy.Cipro outer layer.
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Figure 2.9. A) Cyclic voltammogram of PEDOT:PSS-CHI fibre in PBS (pH ⋍ 7.4)
scanned between -1.0 V and +0.8 V at a scan rate of 25 mV/s before and after
electropolymerisation of Ppy.Cipro layer (current density: 2.0 mA/cm2 and
polymerisation time: 10 min). Arrows indicate the direction of potential scan. B)
Electrochemical impedance spectroscopy of wet-spun fibres in comparison to a Pt
wire in PBS.

Figure 2.9-B shows lower impedance of the PEDOT:PSS-CHI-Ppy.Cipro (~2.8
kΩ/cm2) at 1.0 kHz (relevant frequency of biological activities [1, 17]) in
comparison to platinum wire (~ 10.3 kΩ/cm2). This improved impedance resulted
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from facilitated penetration of ions over a much higher electroactive surface area
compared to the Pt wire (as a common metal to use in neuroprosthetic electrode [1])
due to the gel-like nature of the hybrid fibre. Moreover, the impedance of fibres did
not change after polymerisation of Ppy.Cipro.
The mechanical properties of PEDOT:PSS-CHI-Ppy.Cipro fibres were enhanced
compared to their as-spun counterparts. Modulus, strength and breaking strain of
PEDOT:PSS-CHI-Ppy.Cipro fibres, obtained from stress–strain curves, were
calculated to be 2.9 ± 0.2 GPa, 128 ± 11 MPa, 30.5 ± 4%, respectively (Figure 2.10).
The as-dried EG-treated PEDOT:PSS-CHI fibres displayed modulus, strength and
breaking strain of 2.0 ± 0.3 GPa, 99 ± 7 MPa, 20.6 ± 1.2%, respectively.

Figure 2.10. Stress–strain curves of PEDOT:PSS-CHI and PEDOT:PSS-CHIPpy.Cipro fibres.

3.3.3 Release profiles of ciprofloxacin hydrochloride
The release of Cipro from the Ppy.Cipro layer was performed under passive and
electrical stimulation conditions in PBS (pH ⋍ 7.4) at 37 oC in a 3-electrode cell. A
92

1.0 cm length of PEDOT:PSS-CHI-Ppy.Cipro fibre was placed in PBS with samples
taken at various time intervals. Electrically stimulated release was performed under
potentials that induced an oxidised (+0.3 V vs Ag/AgCl) and reduced (-0.26 V vs
Ag/AgCl) state in the Ppy.Cipro layer. These potentials were chosen from the
PEDOT:PSS-CHI-Ppy.Cipro CV shown in Figure 2.9-A.
The release measurements of Cipro have been carried out using UV.Vis spectroscopy
and the calibration curve of Cipro was calculated on the basis on the UV.Vis spectra
shown in Figure 2.11-A. As Figure 2.11-B demonstrates, there is no peak observed
for the fibre components in the window of 200-300 nm, where the Cipro peak occurs.
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Figure 2.11. A) UV.Vis spectra of Cipro in PBS with different concentrations of
Cipro, B) spectrum of fibre residual (dispersed fibre in PBS), C) calibration curve of
Cipro at different concentrations.
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The passive release of Cipro showed short-term release for the first 8.0 hr (Figure
2.13-B) followed by a plateau up to 72 hr (Figure 2.13-A). These results suggest that
under passive conditions, Cipro release is dominated by diffusion of near-surface
trapped Cipro. According to the Raman data (Figure 2.8) and the high electrical
conductivity of the fibres, the Ppy.Cipro layer is in its conducting state; therefore Ppy
tends to retain its dopant to balance the charge along the polymer backbone to
maintain neutrality. As the interaction between dopant and polymer comes from
electrostatic forces, passive Cipro release is predominantly the result of drug that is
near the surface or loosely trapped within the layer.

The stimulated release profiles of Cipro from the Ppy.Cipro layer of the
PEDOT:PSS-CHI-Ppy.Cipro fibre are shown in Figure 2.12-A. When the
PEDOT:PSS-CHI-Ppy.Cipro fibre is electrically stimulated with constant potential,
so that the Ppy.Cipro layer is in the oxidised state, the release profile is very similar
to the passive release. The main difference is that in the oxidised state, the amount of
Cipro release has decreased. When a reducing potential is applied to the
PEDOT:PSS-CHI-Ppy.Cipro fibre, longer term sustained release up to 72 hr is
observed with approximately two times higher concentration of released drug
compared to the passive mode. The standard deviation of release amount is higher in
reduced state compare to oxidised and passive states possibly due to the higher
amount of drug which was released. However, the difference between Cipro amounts
still is significant.
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Figure 2.12. A) Cumulative release profile of Cipro in PBS from PEDOT:PSS-CHIPpy.Cipro fibres in different conducting states up to 72 hr. B) cumulative release
profile of Cipro in PBS from first 20 min till 8.0 hr. The release experiments were
carried out in PBS (pH ⋍ 7.4) at 37 oC. Error bars indicate the standard error of the
mean (n = 3).

During reduction of Ppy.Cipro, an excess negative charge is placed along the
polymer backbone. Therefore, in order to balance this charge the polymer can either
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release its negatively charged Cl- dopant or incorporate cations from the media it is
residing in. We have previously shown that Cl- ions are very mobile and are readily
expelled upon Ppy electrochemical reduction [30]. As the dopant is expelled, so is
the drug that was physically entrapped during synthesis as reported before for NT-3
delivery [18]. It has previously been shown that the dopant plays an important role in
determining the extent of release of the entrapped drug [31]. In the oxidised state
around 20 % less Cipro is released in comparison to passive conditions over 72 hr.
When the Ppy.Cipro is further oxidised, the polymer possesses a positive charge and
therefore the Cl- dopant is retained within the Ppy.Cipro layer. It is likely that the
positive charge is balanced by uptake of negative ions from the PBS solution.
However, it is clear that upon oxidation Cipro release is observed, albeit not to the
same degree as when in the passive or reduced state. In addition, release experiments
have also been carried out by switching the potential between the reduced and
oxidised states of Ppy.Cipro, demonstrating the capability to tune the release profile
of the conducting polymer fibres (Figure 2.13).
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Figure 2.13. Percentage of drug amount (Mt) released relative to drug loading (Mtot)
from fibres. The switchable drug release experiments were carried out in PBS (pH ⋍
7.4) at 37 oC. Error bars indicate the standard error of the mean (n = 3).

The control of release demonstrated here, based on charge application, highlights the
versatility of our fibres for drug delivery systems for drugs with ionic charge on their
structures. The mechanism for Cipro release is proposed to involve electrostatic
interactions as the application of an electrical stimulation protocol varied the amount
of Cipro release. However, both the ionic and hydrophobic properties of polypyrrole
have been shown to vary upon application of electrical stimulus. The expansion and
contraction (actuation) [29] of polypyrrole is also a well-documented property of
polypyrrole upon oxidation and reduction, and these processes may be involved in
the release of Cipro. As all of these properties change simultaneously it is not
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possible to separate them to determine which process is the dominant factor driving
this release.
2.3.6 In vitro antibacterial efficacy
The previous section clearly demonstrates that it is possible to incorporate and
release Cipro from the fibres in a controlled manner. However, it is important to
evaluate whether the Cipro maintains its antibacterial properties during the
fabrication process. The formation of a zone of inhibition (ZOI) within a lawn of
bacteria was used to evaluate the efficacy of released Ciprofloxacin. A ZOI
represents inhibition of the growth of an organism within a designated zone
corresponding to the presence of an active substance. In this study, the ZOI of Cipro
was determined for representative Gram-positive and Gram-negative bacteria.
Firstly, the drug loaded and control fibres were applied to lawns of each bacterial
strain (Figure 2.14).

Figure 2.14. Zone of inhibition (ZOI) of three different fibres against A) S. pyogenes,
B) E.coli. (i: PEDOT:PSS-CHI-Ppy.Cl), (ii: PEDOT:PSS-CHI) & ( iii: PEDOT:PSSCHI-Ppy.Cipro). Each sample was repeated 3 times.
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A ZOI was observed surrounding the drug loaded fibres (Figure 2.14) placed on the
lawns of each bacterial strain, but not surrounding the underlying PEDOT:PSS fibre,
nor PEDOT:PSS-CHI-Ppy.Cl fibres. These results confirm that the inhibition of
bacterial growth was solely due to the presence of ciprofloxacin in these fibres. The
absence of a ZOI surrounding the control fibres (PEDOT:PSS-CHI and
PEDOT:PSS-CHI-Ppy.Cl) shows that the components of these fibres do not display
any antibacterial effect. The inhibition of bacterial growth indicates that the
associated processing steps required to prepare these fibres do not adversely affect
the bioactivity of the ciprofloxacin under passive release conditions. Moreover, the
amount of drug loaded and subsequently released from the fibre under passive
conditions was sufficient to diffuse through the agar media to affect bacterial growth.
Secondly, the effect of the method of Cipro release from the fibres on its efficacy
was investigated (Figure 2.15). Cipro-containing media collected after 72 hr of
cumulative release was loaded onto bacterial lawns via paper discs. The release
medium obtained following application of electrical stimulation, at both oxidising
and reducing potential, resulted in maintained antibacterial activity, which indicates
that electrical stimulation did not disrupt drug biological activity.
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Figure 2.15. Zone of inhibition (ZOI) of three different drug release media after 72 hr
cumulative release against A) E. coli and B) S. pyogenes strain. (i: 1.0 µg Cipro), (ii:
drug release in reduced state), (iii: drug release in oxidised state), (iv: drug release in
passive state). Each sample was repeated 3 times.

This study importantly confirms that Cipro maintains its bioactivity against both
Gram-positive and Gram-negative bacteria during loading via electrochemical
polymerisation and the subsequent electrically stimulated release. Moreover, zones
of inhibition (ZOI) obtained using 72 hr cumulative release samples against E. coli
and S. pyogenes correlated well with the trend of cumulative release profiles in
passive, reduced and oxidised states of the fibres (Table 2.4). However, the zone of
inhibition is not significantly different in reduced compared to passive state. This
may be attributed to the fact that the amount of Cipro used on all paper discs was
higher than the minimum effective Cipro dose that was required to kill the bacteria,
therefore, causing a drug saturation effect in the culture.
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Table 2.4. Zone of inhibition resulting from the application of volumes of release
medium obtained under different conditions onto lawns of bacteria via paper discs.
Averages of three independent experiments are shown with standard errors.

Samples

Mt/Mtot (%)a

Reduced

Zone of Inhibition (mm)
E. coli

S. pyogenes

88.0 ±14.0

26.6±0.9

14.3±0.3

Passive

47.1±1.2

27.3±0.3

14.0±1.0

Oxidised

36.5±0.5

22.7±2.8

12.0±1.2

1.0 µg

NA

31.3±0.6

15.0±0 0

a.

The percentage of Cipro released was determined from the release profiles
presented in Figure 2.13.

2.3.7 Cell growth studies
In order to utilise the fibres in biomedical applications, an understanding of their
biocompatibility is critical due to the fact that toxicity of some materials is one of the
obstacles in their applications to biological systems.
Previous studies have shown that a concentration less than 150 µg/ml ciprofloxacin
hydrochloride had no adverse effect on proliferation and differentiation of a variety
of cell types including primary cultures of astrocytes and primary fibroblast cell lines
[32, 33]. The cytotoxicity of our fibres was tested in the presence of B35
neuroblastoma cells, chosen as a neural cell model due to the intended application of
these fibres as neural recording/stimulation electrodes with controlled drug release.
The presence of metabolically active cells in the presence of drug-loaded fibres was
examined using Calcein AM, whereby the production of a green fluorescent product
indicates living, viable cells. The acetomethoxy derivate of calcein (calcein AM) is a
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common indicator in biology for cell viability tests since it can be transported
through the cellular membrane into live cells. An acetomethoxy group conceals the
part of the molecule that chelates Ca2+, Mg2+, Zn2+ and other ions. After transport
into the cells, intracellular esterases eliminate the acetomethoxy group; the molecule
gets trapped inside and gives out strong green fluorescence. As dead cells do not
have active esterases, only live cells are labelled. In our experiments, a counter stain
(propidium iodide) was also used to indicate the presence of membranecompromised cells, indicated by red fluorescence. Following 72 hr incubation, the
cells surrounding the fibres were observed to show green fluorescence indicating
them to be metabolically active with minimal presence of membrane compromised
cells (Figure 2.16-A, B and C). These results together indicate the cytocompatibility
of our fibres.

Figure 2.16. B35 neural cells cultured on A) PEDOT:PSS-CHI, B) PEDOT:PSSCHI-Ppy.Cl, and C) PEDOT:PSS-CHI-Ppy.Cipro fibres over a period of 72 hr (scale
bar 800 µm). Calcein AM/PI staining renders metabolically active and membrane
compromised cells bright fluorescent green and red respectively.
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Figure 2.17. LDH release cytotoxicity assay on the effects of a dilution series of
Cipro against B35 cells after 48 hr incubation. Error bars indicate the standard error
of the mean (n = 3).

In order to test the possible toxicity of ciprofloxacin on cells growth, a Lactate
Dehydrogenase (LDH) release assay was performed in the presence of a dilution
series of Cipro and assessing LDH released into the media as a marker of dead cells.
The results showed Cipro concentrations ≤ 125 μg/ml demonstrated no significant
toxicity against B35 neuroblastoma cells. In addition, Cipro concentrations ≥ 250
μg/ml showed toxicity against B35 neuroblastoma cells (Figure 2.17). The results
proved that the dosage of Cipro released from fibres is not high enough to cause cell
mortality.
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2.4 Conclusion
This chapter demonstrates a facile approach to produce new conducting polymerbased fibre that can be utilised as a micro-electrode for drug delivery applications.
The controlled release of ciprofloxacin hydrochloride was achieved by electrical
stimulation of a second conducting polymer layer. The antibacterial efficacy of the
incorporated and released ciprofloxacin was confirmed against Gram-positive and
Gram-negative bacteria indicating the stability of the antibiotic properties of the drug
during both processing and the release method employed. In addition, cell culture
studies on the fibres showed B35 neuroblastoma cells were not adversely affected by
the presence of the Cipro loaded fibres, nor any released products from the fibres.
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WET-SPINNING
AND
ELECTROSPINNING: NEW FABRICATION
METHOD
TO
ENHANCE
CYTOCOMPATIBILITY
OF
CONDUCTING
FIBRES
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3.1 Introduction
One of the main challenges in tissue engineering is to design and fabricate an
appropriate artificial 3D extra cellular matrix (AECM) compatible with the in vivo
environment to provide additional control over cell behaviour [1]. The composition
and mechanical properties of AECM are some of elements that determine their
performance [2]. AECM fabricated from submicron dimension materials provides a
better biomimetic structure due to the interaction of cells with nanostructured
surfaces [2]. To this end, significant control over cellular behaviour including
adhesion, proliferation, migration, and differentiation has been achieved using
electrospun fibres [3].
Electrospinning is a well-established and versatile technique used to produce
submicron fibres. A vast range of polymers including, conducting and natural
polymers have been used [2, 4-7]. The diameter of electrospun fibres is typically in
the sub-micron and nanometer size range and this can facilitate cellular interactions
[2, 3, 8]. Moreover, a scaffold made from aligned electrospun fibres, as opposed to
non-aligned electrospun fibres, provides a more attractive substrate since cell
adhesion, alignment and proliferation can be improved by the geometry and
arrangement of the electrospun fibres [9, 10]. This positive effect is more
pronounced when the AECM is designed to aid in regeneration of a specific tissue
type such as nerves, tendon or muscle, where the cells must be aligned parallel to
each other to form the final tissue [2, 9, 10]. Besides mimicking the AECM, the
migration and extension of cells can be driven by the orientation of electrospun fibres
in a 3D scaffold. Aligned poly(l-lactic acid) (PLA) nanofibres successfully directed
neurites sprouting from neonatal mouse cerebellum (C17.2 NSCs) with 100 m long
axons [11]. Alignment in electrospun fibres also facilitates the healing process of
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scars by directing the migratory routes of cells in specific directions [8]. For
example, electrospun layers of poly caprolactone (PCL) and collagen fibres were
fabricated and normal human dermal fibroblast (NHDF) cells were injected between
the layers to generate a layer-by-layer cell assembly. The cells remained within the
different layers and were shown to form dermal-like tissues or bilayer skin tissues
after 1 week of culturing [12].

Methods that are used to control the alignment of electrospun fibres can be mainly
classified into three groups based on the nature of the forces utilised to control the
collection of the electrospun fibres. These forces are mechanical, electrostatic, and
magnetic [6, 13-15]. In the case of mechanical force, a high speed-rotating spool is
usually used to collect aligned electrospun fibres. In this method, the rotating speed
of the spool controls the degree of alignment of the unidirectional non-woven sheath.
Since electrostatic charges are carried by the electrospinning jet, manipulation of the
electric/magnetic field can apply effective forces to the electrospun fibres just before
their collection to control the alignment [6, 7, 13-15]. These methods, whilst useful,
cannot produce continuous and unlimited lengths of aligned/unidirectional
electrospun fibres. Another challenge associated with aligned electrospun fibres is to
preserve the porosity of the final structure made from electrospun fibres [15].

Artificial ECM fabricated from conducting polymers can offer intriguing platforms
for tissue regeneration due to the ability to enhance cellular growth via electrical
stimulation as well as to control the release of incorporated biological molecules
[16]. Topographical design and cyctocompatibility of the conducting AECM are
critical factors that determine cell attachment to the AECM and the ability to transfer
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the electrical signals to the cells [17]. Therefore, integration of conducting polymers
into a cytocompatible electrospun scaffold is a great step toward utilising them in
regenerative medicine.

In this chapter, we introduce a novel and facile method to integrate unidirectional
electrospun PLGA fibres with a micron dimension PEDOT:PSS-CHI wet-spun fibre.
The fibres showed a porous structure with suitable electrochemical and mechanical
properties. Modulated drug release was achieved and introduction of porous PLGA
improved the cell attachment. The structure simultaneously takes advantage of the
high conductivity of PEDOT:PSS and the enhanced interactions between cells and
the sub-micron structure environment provided by unidirectional aligned
cytocompatible polymer electrospun fibres. The interaction of B35 neuroblastoma
cells on the fibres were studied using fluorescent staining and cryo-SEM techniques.
The antibiotic Ciprofloxacin hydrochloride (Cipro) was also incorporated into the
fibre to provide antibacterial properties. The release of the Cipro from these fibre
structures was also investigated.
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3.2 Experimental
3.2.1 Materials
Poly(3,4-ethylenedioxythiophene) poly(styrene sulfonate) (PEDOT:PSS) pellets
were obtained from Agfa (Orgacon dry, Lot A6 0000 AC). Ethanol (75 %), dimethyl
sulfoxide (DMSO) and paraformaldehyde (PFA) were purchased from Sigma.
Details of PEDOT:PSS, chitosan (CHI) and ciprofloxacin hydrochloride (Cipro)
properties have been discussed in Chapter 2. PLGA (75:25) was purchased from
Purac (Singapore). B35 neuroblastoma cells line was gifted by Dr. Anita Quigley at
St. Vincent Hospital in Melbourne. Dulbecco's modified Eagle's medium (DMEM),
fetal bovine serum (FBS), penicillin/streptomycin (Pen/strep) were purchased from
Invitrogen. Anti-beta III tubulin primary antibody was obtained from Covance,
Alexa fluo546 anti mouse secondary antibody and 4',6-diamidino-2-phenylindole
(DAPI) were obtained from Invitrogen (Melbourne, Australia).

3.2.2 Combined wet-spinning and electrospinning method
A spinning solution of 25 mg/ml of PEDOT:PSS was prepared by dispersing
required amounts of PEDOT:PSS pellets in water followed by homogenising at
10000 rpm for 10 min similar to the procedure described in Chapter 2. The
PEDOT:PSS dispersion was loaded into a 5.0 ml syringe with a detachable needle
(20 gauge) as the spinneret. The feed ratio applied for wet-spinning was 15 ml/hr
using a syringe pump (KDS-Scientific 100). A concentration of 1.0 wt. % chitosan
(CHI) was dissolved in 2.0 wt. % acetic acid and was used as the coagulation bath.
The wet-spinning procedure described in Chapter 2 was used to form the
PEDOT:PSS-CHI fibres. 15 wt./v % poly lactic-co-glycolic acid (PLGA) (75:25)
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was prepared in a mixture of dichloromethane and dimethylformamide (DCM:DMF)
(50:50). A feed rate of 1 ml/hr and applied potential of 15 kV was used to electrospin
smooth, bead-free electrospun fibres. The composite wet-spun-electrospun fibres
were prepared by electrospinning PLGA onto the PEDOT:PSS-CHI fibres as they
passed through the ethanol bath.

3.2.3 Electrochemical properties of fibres
The electrochemical properties of fibres was investigated via cyclic voltammetry
(CV) in phosphate buffered saline (PBS) pH ~ 7.4 in a 3-electrode cell, using a
platinum mesh counter electrode, an Ag/AgCl reference electrode and a
PEDOT:PSS-CHI-PLGA fibre as the working electrode with the set-up described in
detail in Chapter 2.

3.2.4 Mechanical properties characterisation of fibres
The mechanical properties of the fibres were evaluated by a Shimadzu tensile tester
(EZ-S) at a strain rate of 0.5 %/min. In order to hold the fibres, they were mounted
on aperture cards (1.0 cm length of window) then fixed using commercial superglue
and allowed to air dry.

3.2.5 Size distribution and imaging of fibres
The morphology of fibres was characterised by field scanning electron microscopy
(FESEM) (JEOL JSM-7500FA). Fibre specimens for cross-section images were
prepared by immersing in liquid nitrogen for 2.0 min followed by fracturing. The
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size distribution of electro-spun fibres was determined by evaluating the diameter of
fibres (250 measurments) using SEM images and Image-J software.

3.2.6 Ciprofloxacin hydrochloride release measurement
The release of Cipro from electrospun PLGA was measured using UV.Vis
spectroscopy by determining the absorption of Cipro at its λmax (270 nm) in PBS.
The UV–Vis spectra of Cipro in PBS solutions containing Cipro at varying
concentrations (0.1-5.0 µg/ml) were recorded between 200 nm and 300 nm using a
Shimadzu

UV

1601

spectrophotometer

in

order

to

construct

an

absorbance/concentration calibration curve for sample analysis.

3.2.7 Cell culture and seeding
In order to culture cells, a B35 neuroblastoma cell line was sub-cultured on tissue
culture plate (TCP) with Dulbecco's modified Eagle's medium DMEM medium
supplemented with 10 % (v/v) fetal bovine serum (FBS) to passage (8-9) to use in the
experiments. Cell passaging was carried out at a splitting ratio of 1:5 when the
culture reached 70–80% confluence. To seed cells onto the fibres, cells were
trypsinised, centrifuged, and re-suspended in DMEM supplemented with 10 % FBS
and 1 % Pen/Strep at a final concentration of 1 × 105 cells/ml. The fibres were placed
onto glass slides in an aligned pattern followed by glueing four-well chambers on the
glass slide (Figure 3.1). The surface of fibres was sterilised by rinsing with 70 % v/v
ethanol. After drying of fibres in a biosafety cabinet, cells were seeded at a density of
5,000 cells/cm2 for proliferation studies. Cells were placed in an incubator at 37 °C in
a humidified 5% CO2 environment for 48 hr prior to staining and imaging.
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In addition, cells were seeded in a density of 10,000 cells/cm2 on fibres and
differentiated by replacement of growth media with differentiation media containing
DMEM, 1.0 % horse serum and 1 mM cAMP, and incubated for 72 hr with feeding
after 48 hr. The schematic set up of fibres under four-well chambers is shown below.

Figure 3.1. Schematic of the cell culture set up.

3.2.8 Fluorescent staining and imaging of cells
Calcein AM assay
A stock solution of 1.0 mM Calcein AM (Invitrogen) in DMSO was prepared. A
concentration of 5.0 μM in cell growth media was added to cells followed by
incubation for 15 min in cell culture environment (37 oC, 5% CO2). Images were
captured using an AxioImager fluorescent microscope (Zeiss) with AxioVision
software. Live cells stain bright fluorescent green.
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Beta III tubulin immunostaining
In order to perform beta III tubulin staining, the B35 cells were first washed in PBS.
Cells were then fixed using 3.7 % paraformaldehyde (PFA) for 10 min followed by
rinsing with PBS. Cells were then permeabilised with a mixture of methanol:acetone
(50:50) on ice for 5.0 min followed by washing the cells with PBS. Then, cells were
blocked using 10 % donkey serum in PBS for 1.0 hr at room temperature. Cells were
then incubated with primary antibody diluted 1 in 1000 in blocking solution
overnight at 4 °C followed by washing with PBS twice. Cells were then incubated
with secondary antibody diluted 1 in 1000 in blocking solution at 37°C for 1 hour
followed by three PBS washes for 20 min each. Following this, cell nuclei were
stained with DAPI (1 in 1000 in PBS) for 5 min at room temperature and the media
was replaced with PBS for imaging.

Cryo-SEM imaging of cells on the fibres
Cells were fixed by 3.7 % paraformaldehyde (PFA) for 10 min at room temperature.
Then, they were washed and kept in PBS for imaging using a JSM-6490LV SEM.
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3.3 Results and discussion
3.3.1 Introduction of a novel method of combined wet-spinning and electrospinning
Fabrication of appropriate biomaterials structures that accommodate living cells is
one of the key issues in the biofabrication field. In addition to the cytocompatibility
of materials, the architecture and topography are important due to the fact that cells
need to attach to the structure in order to follow its geometry. The PEDOT:PSS-CHI
and PEDOT:PSS-CHI-Ppy.Cipro fibres, described in Chapter 2, showed good ability
to control the release of drugs using electrical stimulation, however they exhibited
poor cell attachment. This chapter discusses the development of a novel and facile
fabrication technique, the physical and electrochemical characterisation of the
composite fibres produced, and the in vitro cytocompatibility of the fibres to develop
a better conducting polymer fibre for cell attachment.

Figure 3.2 presents a schematic of the method used to spin continuous electrospun
wet-spun fibres. In this method, 25 mg/ml PEDOT:PSS dispersion in water was
injected into a chitosan (1.0 wt. %) coagulation bath to form a continuous fibre. The
subsequent washing bath contained ethanol similar to the method employed in Figure
2.1. At the same time, PLGA fibres were electrospun on the top of the ethanol
washing bath. When the electrospun PLGA fibres accumulated on the surface of the
ethanol washing bath, they gradually sink into the ethanol. These electrospun fibres
were collected by the wet-spun PEDOT:PSS-CHI fibre as it emerged from the
washing bath. The PEDOT:PSS-CHI fibres covered with the electrospun PLGA were
then collected on the take-up spool.
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Figure 3.2. Schematic of combined wet-spinning and electrospinning method

In order to investigate the morphology of fibres, scanning electron microscopy
(SEM) imaging was performed. Figure 3.3 shows SEM images of the fibres and
cross-sections of the resulting PEDOT:PSS-CHI-PLGA fibres. As can be seen, the
thickness of the electrospun layer around the PEDOT.PSS-CHI core is relatively
constant (30 ± 5.0 μm, for a feed rate of 1.0 ml/hr) indicating uniform coverage of
the electrospun layer around the wet-spun fibre.

120

Figure 3.3. Scanning electron microscopy (SEM) images PEDOT:PSS-CHI-PLGA
fibre, A) SEM of the fibres in parallel configuration, B) SEM images of cross-section
of fibres: the middle area shows the cross section of PEDOT:PSS-CHI wet-spun
fibre and the edge shows the PLGA electrospun sheath. C) The cross-section of the
fibre at higher magnification.
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The SEM images represent a coherent coating of electrospun PLGA fibres wrapped
around the wet-spun fibres. There is no evidence of this coating peeling away from
the PEDOT:PSS-CHI fibres with preparation for SEM imaging. SEM images also
confirmed the alignment of electrospun fibres as well as the uniform diameter of the
fibres along the fibres’ axis (Figure 3.4). Using this method, as evidenced by SEM
images, the porosity of the final core-shell structure is preserved. This porous
structure most likely occurs when the PLGA electrospun fibres are collected from the
ethanol bath; the ethanol evaporates quickly so that PLGA solidifies and retains its
porous structure. The morphology of PEDOT:PSS-CHI-PLGA fibres at different
magnifications (Figure 3.4) shows that PLGA electrospun sheaths covered the
surface of PEDOT:PSS-CHI fibres.
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Figure 3.4. Scanning electron microscopy images of PEDOT:PSS-CHI-PLGA fibres
at different magnifications. A) PEDOT:PSS-CHI-PLGA fibre at 100X magnification,
B) the same fibre at 200X, C) PLGA electrospun sheath at 500X. The scale bar
represents 100 µm in each image.
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The diameter of electrospun fibres in the outer layer was determined from SEM
images (Figure 3.5-A). Using Image-J software, the size distribution of the PLGA
electrospun sheath is presented in Figure 3.5-B. The mean diameter of the
electrospun fibres is found to be 1.64 ± 0.6 μm.

Figure 3.5. A) Scanning electron microscopy (SEM) image of PLGA fibres in the
electrospun sheath. B) Size distribution of fibres in the electrospun sheath shown in
A.
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3.3.2 The effect of feed rate of PLGA solution
The feed rate of the electrospinning solution was varied from 0.5 to 2.0 ml/hr to
evaluate the effect on the thickness of the electrospun layer. Figure 3.6 presents SEM
images of PEDOT:PSS-CHI-PLGA fibres produced using various feed rates.
Increasing the feed rate resulted in thicker fibres collected on the top of wet-spun
PEDOT:PSS-CHI fibres. Fibres with feed rates of 0.5, 1, 1.5 and 2 ml/hr, produced
sheath thicknesses of 39±6, 57±8, 70±8 and 80±5μm, respectively. The diameter of
PEDOT:PSS-CHI core fibres was constant (111± 5μm) since the wet-spinning
parameters such as feed rate, spinneret diameter and collecting speed were kept
constant during the spinning process.
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Figure 3.6. Scanning electron microscopy images of cross-sections of the
PEDOT:PSS-CHI-PLGA fibres with respect to electrospinning feed rate. A) 0.5
ml/hr, B) 1 ml/hr, C) 1.5 ml/hr, D) 2 ml/hr. The scale bars in images A, B and C
represent 10 μm, whereas in image D the scale bar represents 100 μm.

3.3.3 Electrochemical properties of fibres
Cyclic voltammograms (CV) of a PEDOT:PSS-CHI fibre and the PEDOT:PSS-CHIPLGA fibre are shown in Figure 3.7. The main features of the CV are as follows:
upon oxidation a peak is observed at ~ +0.2 V, which is followed by a second small
oxidation peak at 0.4 V. Upon reduction the CV exhibits two broad reduction peaks
observed at 0.4 V and -0.1 V. Similar redox responses for both fibres confirmed the
minimum disruption of the access of ions after the addition of the PLGA electrospun
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sheath. The results showthat PEDOT:PSS-CHI fibres are electro-active and have the
capability to switch between reduced and oxidised states [18].

Figure 3.7. Cyclic voltammogram of A) PEDOT:PSS-CHI fibre, B) PEDOT:PSSCHI-PLGA fibre, and C) PEDOT:PSS-CHI fibre coated with PLGA film in PBS (pH
⋍ 7.4) scanned between Ei = -0.6 V and Ef = +0.8 V at a scan rate of 25 mV/s. The
feed rate of electrospinning was 1 ml/hr. Dashed arrows indicate the direction of the
potential scan.

Cyclic voltammetry performed on the PEDOT:PSS-CHIT-PLGA fibre, where a feed
rate of greater than 1 ml/hr was used to form the PLGA electrospun sheath, resulted
in the loss of electroactivity (the sheath was too thick for PBS to penetrate). This is
presumably due to the thick layer of PLGA, that forms at these high feed rates (as
indicated in Figure 3.6), preventing the PBS electrolyte from diffusing to the
PEDOT:PSS core. PLGA fibres spun at a feed rate of 1 ml/hr or less provided
suitable thicknesses through which ions could diffuse to the PEDOT:PSS, resulting
in measurable electroactivity of the fibre (Figure 3.7). In order to preserve the
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electrochemical property of the fibres, the electrospinning feed rate was kept at 1
ml/hr for subsequent experiments. It is worth mentioning that when the PEDOT:PSSCHI fibres were completely coated by a layer of PLGA (by dip-coating the fibres
into a PLGA solution of the same concentration used for electrospinning) it was not
possible to record any electrochemical response (Figure 3.7). This non-porous
coating of PLGA would not permit the diffusion of PBS ions into the inner
conducting PEDOT:PSS-CHI core.

3.3.4 Mechanical properties of the fibres
The mechanical properties of PEDOT:PSS-CHI-PLGA fibres were evaluated by
tensile tests and the resultant stress-strain curves. The total diameter of the fibres was
measured including the compact PEDOT:PSS-CHI and the porous PLGA
electrospun layer.

Figure 3.8. Stress-strain curve obtained from a PEDOT:PSS-CHI-PLGA fibre.
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The as-dried PEDOT:PSS-CHI-PLGA fibre revealed modulus and ultimate stress of
420 MPa and 16.5 KPa, respectively. The lower calculated ultimate stress and
modulus of the fibres compared to the neat PEDOT:PSS-CHI fibres (Chapter 2.
Figure 2.11) are due to the larger diameter of the fibre which includes the porous
PLGA electrospun sheath.

The fibres were easily handled, which made it possible for them to be utilised in cell
culture studies. Unlike other wet-spun fibres (i.e PEDOT:PSS fibres), the novel
composite fibres produced here did not swell in cell culture medium, possibly due to
the presence of the PLGA electrospun sheath.
3.3.5 Release of ciprofloxacin hydrochloride from fibres
The multi-functionality of the PEDOT:PSS-CHI-PLGA fibres was established by
incorporation of an antibacterial drug (ciprofloxacin hydrochloride) into the structure
during electrospinning. Ciprofloxacin hydrochloride was combined into the
electrospinning solution to be loaded in the fibre. The drug is released by degradation
of the PLGA electrospun layer as well as by diffusion of the drug from the PLGA
fibres [19]. Figure 3.9 presents the release profile into PBS over 28 days. A burst
release within the first few days was observed followed by sustained release for the
following 27 days. The burst release is most likely due to discharging of Cipro from
the surface of the electrospun sheath into the PBS media [19]. Moreover, release
from the PEDOT:PSS-CHI-PLGA fibres without Cipro loading did not show any
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peak at 270 nm (max for Cipro) which confirms that no non-drug products released
from the PEDOT:PSS-CHI interfered with the drug detection.

Figure 3.9. Cumulative release profile of Cipro from PEDOT:PSS-CHI-PLGA fibres
in PBS medium.

3.3.6 Cytocompatibility of the fibres
The micro-dimensional fibres (PEDOT:PSS-CHI) made by wet-spinning can provide
electrochemical activity, while the sub-micron dimensional electrospun fibres were
expected to improve cell attachment to the multifunctional structure. In order to
investigate the cytocompatibility of the fibres, B35 neural cells were seeded on
PEDOT:PSS-CHI-PLGA fibres laid in a parallel configuration on the surface of a
glass slide. B35 cell adhesion onto the fibres was investigated in order to evaluate the
suitability of the fibre to be used in neural tissue regeneration. The cells were
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cultured on tissue culture plastic (TCP) as control, fluorescently stained for -tubulin
(neural marker) and imaged using optical microscopy. Images in Figure 3.10
illustrate the B35 neural cells cultured on TCP for 2-4 days and immunostained for
-III tubulin.

Figure 3.10. Beta III tubulin staining imaging of B35 neural cells on TCP. A) In
growth media after 2 days. B) In differentiation media after 4 days.

Figure 3.11 represents the results of beta III tubulin staining performed on B35 cells
on the fibres. Cells attached to PEDOT:PSS-CHI-PLGA fibres (Figure 3.11A-C)
and moved into the electrospun sheath. For DAPI images, the blue spots represent
nuclei of cells which penetrated into layers of the electrospun sheath, however, the
beta III tubulin images (Figure 3.11B-F) did not show the cytoskeleton of cells well.
This is due to PLGA fluorescing at the same wavelength that is required for detection
of beta III tubulin (red areas on fibres without cells).
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Figure 3.11. Beta III tubulin staining imaging of B35 neural cells on fibres. A, C and
E) DAPI staining after 2 days in growth media. (Blue spots represent nuclei of cells)
B, D and F) Purple spots represent nuclei and cytoskeleton of cells together (merged
images).
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Since, in the case of beta III tubulin staining, there was a problem with
autofluorescence of PLGA in the red channel, calcein AM staining was performed in
order to illustrate the viability of the cells. Figure 3.12 (A-F) revealed live cells in the
surface of electrospun fibres and pore bridging (connection of cells between two
electrospun fibres) with no evidence of dead cells on the surface of fibres, whereas
Calcein AM staining of B35 cells on PEDOT:PSS-CHI fibres (developed in Chapter
2) resulted in poor cell attachment to the fibres (Figure 3.12-H) and their
agglomeration on the surface of fibres (Figure 3.12 G) with some dead cells detected.
In addition, the higher specific surface area of the PLGA electrospun sheath provided
improved cell attachment compared to the PEDOT:PSS-CHI wet-spun fibre. When
cells spread and fill the spaces between the individual electrospun fibres, they are in
direct contact with other cells forming cell-connected tissue-like structures (Figure
3.12 B and D). These results are similar to that of other researchers working with
electrospun silk for tissue engineering [20]. The balance between fabricating a
suitable ECM for cells and the challenges of this from an engineering point of view
highlights the difficulties of building an optimised tissue-engineering scaffold.
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Figure 3.12. Calcein AM images of B35 cells on PEDOT:PSS-CHI-PLGA fibres. (A,
B, C and D) at low magnification (10X), (E and F) at high magnification (50X). (G
and H) PEDOT:PSS-CHI fibres with cells.
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As the cells spread into the electro-spun layers, they followed the direction of the
long micro-dimensional fibres. Cryo-SEM images of fibres (Figure 3.13) show cells
differentiating on the fibres with the electrospun sheath hosting axons and guiding
their direction. In images A, C and E, cells proliferated on the surface and migrated
into the layers, however in images B, D and F, cells started to differentiate. Some
directed axons of cells can be observed in Figure 3.13 B-F and are marked using
black arrows. It is worth noting that since the majority of cells migrated into the
electro-spun sheaths, it was hard to quantify the lengths of axons. These results
showed that the PLGA electrospun sheaths on the surface of the fibres facilitate cells
attachment by providing a cytocompatible platform, while the porosity of the
electrospun layer would be expected to provide benefits for the transport of nutrients.
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Figure 3.13. Cryo-SEM images of B35 neural cells on PEDOT:PSS-CHI-PLGA
fibres at different magnifications. (A, C and E) B35 cells in growth media after 2
days. (B, D and F) cryo-SEM images of the differentiated B35 cells for three days on
fibres (the black arrows show the direction of axons on the electro-spun sheaths).
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3.4 Conclusion
This chapter describes the development of a novel and facile fabrication technique,
which is the combining of electrospinning and wet-spinning simultaneously. The
method discribed here is not limited to PEDOT:PSS and PLGA but has the capability
to be applied to other spinable polymers. This technique has the capability to produce
conducting biomaterials with the potential to release an antibiotic drug
(ciprofloxacin) within 28 days in PBS. The physical characterisation of the fibres
viewed in cross-section revealed a solid PEDOT:PSS-CHI wet-spun fibre covered by
a porous PLGA electrospun sheath without peeling off the electrospun from wetspun fibres. The electrochemical characterisation of the fibres demonstrated the
electroactive behavior of the PEDOT:PSS-CHI core in PBS, which was not
adversely affected by covering of the fibres with the PLGA electrospun sheath. The
in vitro cytocompatibility tests of the fibres for the B35 neuroblastoma cells line
including fluorescent staining and Cryo-SEM imaging techniques demonstrate the
cytocompatibility of PEDOT:PSS-CHI-PLGA fibres due to the fact that B35 cells
attached to the surface of the fibres and migrated into the electropsun sheaths, as well
as their differentiation on/into PLGA electropsun sheaths. All the mentioned
properties above suggest the potential of PEDOT:PSS-CHI-PLGA fibres for
utilisation in biomedical fields.
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4 WET-SPINNING OF MULTIFUNCTIONAL
PLGA-GRAPHENE FIBRES
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4.1. Introduction
Synthesis and fabrication of conducting biomaterials in 3-dimensional (3D)
architectures are likely to be an integral part of the field of regenerative medicine.
Biocompatibility and degradation in conjunction with cellular affinity to the 3D
structures are some of key features to consider in developing appropriate structures.
Moreover, biocompatible 3D structures fabricated from conducting polymers can
offer very interesting platforms for cells due to their capability to modify cellular
growth via electrical stimuli as well as controlling the release of biological molecules
[1, 2].

A range of organic conductors such as carbon nanotubes and conducting polymers
have been utilised to induce or enhance electrical conductivity in biomaterials [3-5].
The debatable toxicity issue of carbon nanotubes, due to the inclusion of metal
catalysts as well as their aspect ratio, limits their application in biomedical fields [6].
Conducting polymers also suffer from the fact that their electrochemical stability is
relatively low in aqueous solution [7, 8]. On the other hand, graphene, a novel 2D
conductor, presents high conductivity, electrochemical stability as well as in vitro
biocompatibility [9].

Pristine graphene is a tightly packed two-dimensional honeycomb crystal lattice of
sp2 bonded carbon which is only a single atom thick [10]. Graphene has received
increasing scientific attention as a result of its high surface area [11], outstanding
electronic conductivity [12, 13], mechanical properties [14], biocompatibility [11]
and stable electrochemical performance even in physiological electrolyte [11].
However, there are challenges that need to be addressed to take full advantage of
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these excellent properties of pristine graphene. Given the lack of a cost-effective
reliable bottom-up approach for the large-scale production of graphene, attention has
turned to top-down routes that might be able to deliver low-cost, high quality
graphene sheets (refer to chapter 1 for more detail) [15].

Among the various methods introduced for the preparation of graphene [15-24],
liquid-phase exfoliation of graphite using solvent or surfactants (refer to chapter 1
for more detail), revealed promising results. This method has several advantages
compared to others (i.e. graphene oxide route) such as production of graphene in a
liquid phase without any additional oxidation steps and easy processing of the final
products [25]. Processing in a solution not only permits the fabrication of paper-like
structures and/or thin films but also, facilitates the introduction of graphene into
polymer hosts, simplifying the fabrication of composites [26-28]. As such, solventor surfactant-exfoliated graphene has the potential to be employed in composites; this
method is of interest in both research and industry [27-30]. For instance, the blending
of graphene with chitosan and subsequent production of films can be achieved by
dispersing a few layers of surfactant-exfoliated graphene sheets in chitosan
solution followed by a solution-casting method [9]. The elastic modulus of graphene
composite was up to 200% higher than chitosan film alone. The graphene-chitosan
films showed biocompatibility (adhesion and proliferation) for the fibroblast cell line
L929 [9]. Zhao et al. also reported on increasing the mechanical strength of poly
(vinyl alcohol) (PVA) using graphene nanosheets with a 150% improvement of
tensile strength and a nearly 10-fold increase of Young’s modulus at a graphene
loading of 1.8 vol % compared to PVA only films [31].
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Poly lactic-co-glycolic acid (PLGA) is a biocompatible, Food and Drug
Administration (FDA) approved biodegradable polymer, which has been utilised
extensively in biomedical applications such as scaffolds (refer to chapter 1 for more
detail). Inducing electrical conductivity to PLGA through the addition of solvent
exfoliated graphene can enhance its applications in the biomedical field. Moreover,
PLGA-graphene composites in the form of fibres can act as mimetic structures to
enhance cell growth and provide guidance with the appropriate topography of fibres.
In addition, the capability of fibres to be knitted or braided holds promise for the
fabrication of more complex 3D structures to act as tissue-culture scaffolds [32].

In this chapter, liquid phase exfoliated graphene is produced and characterised.
Solvent exfoliated graphene is utilised to induce electrical conductivity in PLGA
polymer structures. The wet-spinning method is employed to spin electrically
conductive and robust composite fibres; followed by materials characterisation of the
fibres. In addition, biocompatibility of the fibres is tested in vitro against skeletal
muscle myoblast (C2C12) cells using fluorescent staining and cryo-scanning electron
imaging techniques as well as biological assay.
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4.2. Experimental
4.2.1. Materials
Dry expandable graphite flakes (3772) was provided by Asbury Graphite Mills USA.
Cyclohexyl-pyrrolidone (CHP) and NMP were from Sigma Aldrich. PLGA (75:25)
was purchased from Corbion purac (Singapore).
4.2.2. Solvent exfoliation of graphene
Dry expandable graphite flakes (3772, Asbury Graphite Mills USA) were expanded
at 1050 °C for 15 seconds. 150 mg of resultant expanded graphite (EG) was added to
15 ml of CHP to make up a concentration of 10 mg/ml. EG was also dispersed in
NMP and DMF (two of the most effective solvents for graphene [33]) for
comparison using the same conditions as above. The dispersions were then sonicated
in a bath sonicator (Branson B2500R-MTH) for between 2.0 to 96 hr. Aliquots were
taken from the dispersions to measure the concentration of graphene as a function of
sonication time. Centrifugation (Eppendorf centrifuge 5415D) was performed at
1000 rpm for 45 min. Two-thirds of the supernatant was taken and retained for
further characterisations.
4.2.3. Preparation of the spinning solutions
A series of spinning solutions of PLGA in CHP (10 mg/ml to 50 mg/ml) was
prepared by dissolving the required amount of PLGA in CHP and stirring overnight.
Similarly for the composite formulations, various concentrations of PLGA (10 mg/ml
to 50 mg/ml) were dissolved in the graphene/CHP dispersion (5 mg/ml). With this
strategy different mass fractions of PLGA to graphene obtained in the spinning
solution.
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4.2.4. Fabrication methods
In order to evaluate mechanical and electrical properties of the produced graphene,
free-standing papers were prepared before the composite production. Free-standing
graphene papers were prepared by vacuum filtration onto porous hydrophobic PVDF
membranes with 400 nm pore size (Millipore, Australia) followed by washing with
ethanol, acetone and water, then oven drying at 70 °C overnight.
In order to prepare the wet-spinning solutions, different amounts of PLGA were
added to the graphene dispersion in CHP (conc. 5.0 mg/ml) to achieve concentrations
between 1.5 to 0.5 wt.% (Table 4.1). Wet-spinning was carried out at room
temperature using isopropanol as a coagulation bath in a vertical set-up (Figure 4.1).
In this arrangement, the PLGA-graphene spinning solutions were injected from the
top (flow rates between 1.0 to 2.0 ml/hr) into a vertical glass column containing the
coagulation bath. As the spinning solution exited the spinneret, the solidification
process

occurred

gradually

using

a

solvent/non-solvent

strategy.

During

solidification, the fibre experiences gravitational force acting on it, resulting in the
fibres being stretched during formation. Fibres were collected by winding onto a
spool and washed several times using ethanol and water to remove remaining CHP,
followed by vacuum oven drying overnight.
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Figure 4.1. Schematic image of vertical wet-spinning set-up.

4.2.5. Characterisation of graphene dispersion
Absorbance measurements of EG in CHP dispersions were carried out using an
UV.Vis spectrometer (Shimadzu, UV-3600 UV-VIS-NIR) at 660 nm and applying
the Beer–Lambert law to measure the concentration of dispersed graphene [34, 35].
The extinction coefficient () was measured for a range of dispersions with known
concentrations between 0.01 to 0.05 mg/ml. This resulted in a mean value of α =
3495 L/gm, which is very close to previously reported α = 3620 L/gm for a graphene
dispersion in NMP [35]. This value was used for other experiments to determine the
weight percentage of graphene in the dispersions using the Beer–Lambert law.
Samples for transmission electron microscopy (TEM) were prepared by depositing a
few droplets of 50 µg/ml graphene dispersion on a holey carbon grid followed by
vacuum oven drying at 70 °C overnight. These samples were examined using a JEOL
JEM-2200FS TEM. The edges of each flake were observed carefully to count the
number of layers per flake. Raman spectra were recorded on a Jobin Yvon Horiba
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HR800 Raman microscope using a 632 nm laser line and a 300-line grating to
achieve a resolution of ± 1.25 1/cm from 1000 1/cm to 3000 1/cm.
For conductivity measurements, 10 ml of diluted dispersion (0.1 mg/ml) was
vacuumed filtered on a hydrophobic PVDF membrane then transferred onto a glass
slide substrate. Then, samples were washed and oven dried (70 °C overnight) before
electrical conductivity measurements. The electrical conductivity of these graphene
papers was measured using a JANDEL resistivity system (Model RM2) with a linear
four-point probe head.
4.2.6. Rheological characterisation of spinning solutions
Viscosity measurements of PLGA-graphene composite formulations in CHP were
investigated in a rheometer (AR-G2 TA Instruments) with a conical shaped spindle
(angle: 2°, diameter: 60 mm). Approximately 2.3 ml of solutions with different
concentrations of PLGA and mass fraction of graphene were loaded into the
rheometer. Viscosity was measured at shear rates between 0.01 to 100 using
logarithmic steps (total 200 points). A solvent trap was employed to prevent CHP
from evaporating during the test. No pre-stressing conditions were applied to avoid
introducing any rearrangement in the system.
4.2.7. Mechanical characterisation of PLGA-graphene fibres
The mechanical properties of the fibres were evaluated by a Shimadzu tensile tester
(EZ-S) at a strain rate of 0.5 %/min. The diameter of fibres was measured using an
optical microscope. In order to hold the fibres, they were mounted on aperture cards
(1.0 cm length window) then fixed using commercial superglue and allowed to air
dry. Young’s modulus (Y), tensile strength (σ) and breaking strain (ε) were
calculated, and the mean and standard deviation reported (n=10).
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4.2.8. Thermal gravimetric analysis (TGA) of PLGA-graphene fibres
In order to determine the ratio of graphene to PLGA in the composite fibres, the
fibres with different graphene contents wet-spun and when dry were cut into smaller
pieces. Small pieces of graphene paper and PLGA fibres were used as control. The
applied heating rate of TGA was 1 °C/min in air from room temperature up to 700
o

C.

4.2.9. Electrical conductivity characterisation
Conductivity of the fibres was measured using a linear four-point probe conductivity
cell with uniform 2.3 mm spacing between probes. The fibres were connected to the
electrodes using silver paint. A galvanostat current source (Princeton Applied
research Model ED402), with currents in the range of 1, 10, 100 and 1000 μA, and
digital multimeter (HP Agilent 34401A) were used to obtain the conductivity (under
laboratory humidity and temperature conditions).
4.2.10. Cyclic voltammetry
A 3-electrode cell was used to characterise the electrochemical behavior of the
PLGA-graphene fibres. A potentiostat (Princeton Applied research Model ED402)
controlled by of EChem version 1.5 software were utilised for cyclic voltammetry. A
three-electrode cell was used where the composite fibre was the working electrode,
an Ag/AgCl was the reference electrode and a platinum mesh was the auxiliary
electrode. All cyclic voltammetric tests were performed in 0.2M PBS (pH~7.4) at
scan rates ranging from 10 mV/s to 100 mV/s.

149

4.2.11. In vitro cell characterisation
Skeletal muscle myoblast (C2C12) cell lines from ATCC (American Type Culture
Collection) was selected due to availability in our laboratory and cultured in DMEM
(Dulbecco's Modified Eagle's Medium, Invitrogen, Sydney, Australia) containing 4
mM L-glutamine (Sigma) and 10% Fetal Bovine Serum (FBS) from Thermo, Noble
Park, Victoria. Primary myoblasts were cultured in Hams F10 (Sigma, Sydney,
Australia) containing 20% (FBS), 2 mM L-glutamine, 2.5 ng/ml bFGF (Peprotech)
and used for experimentation. Antibiotics (penicillin/streptomycin, P/S) were added
to culture media for cell growth media on fibres at 1 % (v/v). Cells were cultured at
37 °C in a humidified, 5% CO2 atmosphere and were subcultured twice weekly when
they reached approximately 90 % confluence.
Calcein AM staining and cryo SEM imaging of cells on PLGA-graphene fibres
5 μM calcein AM in DMSO was added to cell growth media followed by incubation
for 15 min in a cells culture environment (37 °C, 5 % CO2) prior to imaging with a
Leica microscope. (For more details refer to previous chapters). Additionally,
specimens of cells growth on the fibres for cryo SEM imaging were prepared as
mentioned in previous chapters.

Pico green cell number assay
Sterilised PLGA-graphene fibres were placed on glass slides in parallel followed by
gluing 4-well chamber wells on top of them with silicon glue. Cells were seeded at
15 × 102 cells/cm2 and allowed to grow for 72 hr at 37 °C in a humidified 5% CO2
environment. After the incubation period, the growth medium was removed and cells
washed 3 times with PBS to remove non-adherent cells. Remaining cells were lysed
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by the addition 100 μL of 0.1% (w/v) Triton X-100 in Tris-EDTA buffer per well,
followed by a freeze/thaw cycle (-80 °C/37 °C). Cell lysate was then collected and
transferred to fresh 96 well plates along with cell number standards prepared by the
same method. Lysate was then incubated with PicoGreen QuantIT reagent
(Invitrogen) according to the manufacturer's instructions for 15 min, and the
fluorescent signal was read utilising a FluoStar Omega with an excitation of 480 nm
and an emission of 520 nm. The fluorescent signal obtained was converted to cell
number based on cell number standards. Statistical differences were assessed using
ANOVA t-test, with a 95% confidence level.
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4.3. Results and discussion
4.3.1. Solvent exfoliation of graphite
Successful exfoliation of graphite using organic solvents depends on several
parameters including the source of graphite, solvent used and processing conditions
[27]. In the method used here, expanded graphite powder was mixed with an organic
solvent such as NMP followed by sonication [35, 36]. In order to increase the quality
of the dispersion (higher fraction of single layer graphene) and remove the nonexfoliated graphite, centrifugation was applied [35, 36]. Therefore, the correct choice
of starting material (graphite), solvent used and sonication time are the parameters
which were considered to obtain graphene dispersions with higher loading, good
stability and enhanced electrical properties.
Thermal expansion of graphite
In order to increase the efficiency of the exfoliation process, the initial spacing
between the graphite layers (in the graphite precursor) was increased by solid-state
exfoliation of graphite (thermal expansion). The solid-state exfoliation of graphite
has resulted in facilitating the production of graphene oxide [37]. Solid-state
exfoliation of graphite was achieved by thermal expansion of graphite at an elevated
temperature (1050 oC for 15 sec). At such a high temperature, solid-state exfoliation
takes place due to a quick gasification and decomposition of the intercalated
compounds such as sulfur groups, which builds up extremely high pressure between
graphite layers that exceed the van der Waals forces holding the graphene sheets
together [37]. As a result, expandable graphite flakes are transformed to a worm
shape expanded graphite structure (Figure 4.2-B and C) with much higher spacing
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between the edges of graphite layers as shown in the SEM image. These open edges
can facilitate solvent diffusion and easier exfoliation.

Figure 4.2. A) Image of graphite before thermal expansion. B) Optical microscopy
image of a worm shape thermally expanded graphite. C) SEM micrograph of
thermally expanded graphite at high resolution shows open edges, which can
facilitate the diffusion of solvents during the solvent exfoliation process.
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4.3.2. Liquid exfoliation of graphene: the effect of solvent
In order to exfoliate and disperse graphene in a solvent, there should be a strong
interaction between the solvent and the edges of graphite [38]. It has been
demonstrated that the most effective solvents to disperse graphene have a surface
tension of ~ 40 mJ/m2 [38, 39]. Amongst the different organic solvents which are
reported to be effective for solvent exfoliation of graphene, NMP [35] and DMF [40]
(with surface tensions of ~ 41.1 mJ/m2 and 37.1 mJ/m2, respectively) have been
shown to be most effective [35, 40, 41]. Therefore, they were considered for liquid
exfoliation of graphene in this thesis. In addition, cyclohexyl-pyrrolidone (CHP),
which has a surface tension of 38.8 mJ/m2 and is an effective solvent for SWNTs
[42], was also considered for solvent exfoliation of graphene in this thesis for the
first time.

Figure 4.3 shows expanded graphite (EG) dispersions in CHP, DMF and NMP after
8.0 hr bath sonication and left overnight. DMF could not disperse graphene at all and
the graphite particles remained intact after the sonication. In the case of NMP,
graphite turned to fine particles after sonication which entirely settles down at the
bottom of the vial after overnight resting, thus leaving the supernatant liquid
colourless.. On the other hand, the dispersion of EG in CHP was stable with only
some small particles precipitated after overnight resting.
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Figure 4.3. Expanded graphite (EG) dispersions in different solvents after 8.0 hr
sonication and overnight resting. A) CHP, B) DMF, and C) NMP.

Optical microscopy was employed to evaluate the quality of the dispersed graphite
(Figure 4.4). In the case of DMF, large graphite pieces were observed after the
sonication process. In terms of NMP, graphite particles broke down to smaller sizes,
but they were still large enough to be identified under the microscope. However,
CHP contained much finer particles (Figure 4.4-C). The non-exfoliated graphite
particles were removed by mild centrifugation (1000 rpm for 45 min), giving a
homogeneous

and

clear

dispersion.

Therefore,

no

macroscopic

particles/agglomerations could be observed in the final dispersion of graphene in
CHP (Figure 4.4-D). It is worth noting that, no precipitation of particles was
observed for the centrifuged sample, even after being left to stand for one month.
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Figure 4.4. A-C) Optical microscopy images of dispersed graphene in various
solvents, taken immediately after 95 hr sonication. A) DMF, B) NMP, C) CHP, and
D) CHP dispersed graphene centrifuged at 1000 rpm for 45 min.

NMP and DMF have been reported to be very effective dispersants for graphene [27,
28, 33, 35], however, we found that they were ineffective for the dispersion of EG
prepared as described. This discrepancy can be due to the difference between
functional groups in natural graphite that do not exist in the case of EG. It should be
noted that almost all of the available natural graphite contains a portion of impurities
and defects, as indicated by the D band in their Raman spectra [15, 22]. Figure 4.5
compares the Raman spectra of expandable graphite before and after thermal
expansion.
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Figure 4.5. Raman spectra of graphite and expanded graphite (EG) recorded using
630 nm laser line. Spectra are normalised for the G band at ~1582 1/cm.

Raman spectra of graphite and EG are characterised by two sharp peaks between
1000 to 2000 1/cm as follows: the D band at 1325 1/cm and G band at 1582 1/cm.
The G band corresponds to phonons at the Brillouin zone centre [43]. The D band is
either due to breathing modes of sp2 rings or carbon bonds of sp3 nature (present at
the edges or functional groups) [43, 44]. Graphite (before expansion) has a
significant D band, which is commonly seen in natural graphite due to the presence
of impurities and functionalities. In the case of expanded graphite, almost no defectinduced peak (D band) was observed as a result of thermal treatment at an elevated
temperature (1050 oC). However, very low defect density in the expanded graphite
(manifested itself through the absence of the D band) is preferable for the production
of high conducting graphene dispersion, and the absence of functional groups
resulted in NMP and DMF being non-effective for exfoliation.
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Impurities and functionalities in natural graphite might cause some fluctuations in the
surface energy of the graphite. NMP has been reported as the most effective solvent
in terms of liquid exfoliation and stability of graphene dispersions [35]. This might
be due to the fact that NMP can act as a good solvent for graphite containing some
impurities and defects (presence of D band in Raman spectrum) [35]. On the other
hand, low surface functionality and the defect-free nature of EG made NMP less
effective than CHP. It worth noting that CHP is the best solvent for dispersing singlewalled carbon nanotubes which are a kind of defect free/low defect graphite [39].
This finding suggests that CHP is a suitable solvent for dispersing defect free/low
defect graphite either in the form of single-walled carbon nanotubes or thermally
expanded graphite.

Transmission electron microscopy (TEM) was carried out to analyse the exfoliation
state of the dispersed material in CHP. There are always some errors involved in the
determination of the number of layers per flake, as the edges of flakes might not be
very sharp. Careful examination of the edges of a graphene flake at high resolution
showed that the dispersion contained some monolayer graphene (Figure 4.6) and
some multilayers. Electron diffraction patterns also proved the presence of
monolayers [41, 45]. The images in Figure 4.6 A and B are TEM images and
electron diffraction patterns taken from what appears to be a graphene monolayer
and in Figure 4.6 C and D as graphene multilayers.
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Figure 4.6. TEM micrographs of graphene flakes dispersed in CHP and the
corresponding electron diffraction patterns. Images A and B (i and ii) appear to be
monolayers whereas C and D (i and ii) are multilayer graphene. Images A and B (iii)
illustrate the electron diffraction patterns of monolayers, and C and D (iii) images
show the diffraction patterns of multilayer graphene.
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4.3.3. Preparation of graphene paper
In order to demonstrate the processability of the solvent exfoliated graphene, the
dispersion was used to prepare free-standing papers similar to those reported for
carbon nanotubes [46, 47]. The ability to prepare graphene paper can be useful in
many applications such as biomedical applications [7, 11, 48] and energy storage and
conversion [49, 50]. Free-standing papers with thicknesses in the range of 5.0 µm to
100 µm were prepared through filtration of different amounts of graphene
dispersions. The papers are robust and can be bent without breaking. Figure 4.7
shows an image of a free-standing graphene paper prepared by vacuum filtration of
graphene in CHP (5.0 mg/ml) with a thickness of ~ 100 µm.

Figure 4.7. A photograph of a free-standing graphene paper (thickness of ~ 100 µm)
prepared from a dispersion of graphene in CHP (95 hr sonication and centrifuged at
1000 rpm for 45 min).
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SEM analysis in Figure 4.8 shows that a free-standing graphene film contains
graphene flakes that are well-aligned in the plane of the film. It also displays a welldefined layered morphology (Figure 4.8-B). Although the porosity is fairly high, the
graphene flakes building up the paper are reasonably well packed. SEM images
(Figure 4.8-C) show that while the graphene needs to aggregate to form the paper,
the flakes do not restack in a fully ordered assembly similar to graphite, and small
multilayers have a tendency to restack arbitrarily on top of each other.
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Figure 4.8. SEM micrograph of A) a cross-section of a free-standing graphene paper,
B) a cross-section at higher magnification, and C) the surface of the free-standing
paper. (graphene/CHP obtained after 95 hr sonication and centrifuged at 1000 rpm
for 45 min).
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The random stacking of graphene sheets in the free-standing paper is confirmed by
the Raman spectra of the graphene paper. Figure 4.9 shows Raman spectra of
expanded graphite and graphene paper. The graphene paper 2D peak is a single peak
due to the turbostratic nature of disordered graphene layers, while in expanded
graphite, the 2D peak consists of two peaks due to Bernal stacking of graphite [25].
Raman spectra of the papers show 2D bands previously reported for graphene flakes
of three to five layers [25, 34, 44]. Prevention of the ordered restacking of the
graphene flake preserved the electronic structure of the few layers graphene resulting
in the observed Raman spectra.

Figure 4.9. Raman spectra of the free-standing graphene paper and expanded
graphite.

163

Free-standing graphene paper with 6.0 µm thickness had a conductivity of 310 ± 20
S/cm which is higher than the conductivity of free-standing graphene paper prepared
by either surfactant exfoliated graphite (70 S/cm [34]) or NMP exfoliated graphite
(180 S/cm [35]). This superior conductivity is due to the defect-free nature of the
expanded graphite used as graphene precursor (discussed earlier) and makes these
graphene dispersions an excellent choice for production of highly conducting
composites.
4.3.4. Increasing the concentration of graphene
Solvent exfoliated graphene can be used in a range of applications including in the
formation of composites. Preparing highly conducting graphene at a high
concentration in solution is necessary to facilitate production of highly conducting
composites with high loading of graphene [30, 51, 52].
The initial concentration of EG in CHP was limited to 10 mg/ml due to the fact that
higher concentrations of EG (~300 times higher volume than graphite) could not be
wetted by CHP. Therefore, 10 mg/ml of EG in CHP was selected for graphene
preparation.
It was also found that by increasing the sonication time (up to 96 hr), more graphene
was exfoliated and remained dispersed in CHP after centrifugation. The
concentration of dispersed graphene measured by UV.Vis as a function of sonication
time is plotted in Figure 4.10.
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Figure 4.10. Graphene concentration as a function of sonication time. 10 mg/ml EG
in CHP was dispersed using sonication followed by centrifugation at 1000 rpm for 45
min. The concentration refers to the graphene content in the resulting supernatant.

As sonication time was increased, more graphene was dispersed into the solvent up
to the highest concentration at ~ 5.0 mg/ml (0.5 wt. %) after 96 hr sonication (yield
of ~50%). This concentration is significantly higher than the previously reported
values for graphene dispersed in NMP (1.2 mg/ml) obtained after even longer bath
sonication times (460 hr) [35]. This concentration is also higher than most of the
reported values for liquid phase exfoliation of graphene (see Table 1.1). As discussed
earlier, solid-state exfoliation of graphite (thermal expansion) facilitates the solvent
diffusion in between graphite layers to enhance the graphene exfoliation. This solidstate exfoliation was the key factor in achieving high concentrations of dispersed
graphene at a much shorter sonication time.
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4.3.5. Formulation of PLGA-graphene wet-spinning solutions
Since solvent exfoliation of graphene resulted in a stable dispersion with graphene
concentration as high as 5 mg/ml, it is expected that the graphene formulation has the
potential to be used as a filler in composite materials. Composite development can be
facilitated by utilising the exfoliated graphene in liquid to give high concentration of
mono-layer and few-layers graphene sheets (i.e., 5.0 mg/ml here). Apart from the
high concentration of graphene, which can allow for a high mass fraction of
graphene in a composite, the fact that graphene free-standing papers displayed high
conductivity (~300 S/cm for the paper made from the highest concentration of
graphene in CHP) holds promise for development of highly conducting composites.
Therefore, the use of graphene as conducting filler for wet-spun conducting PLGA
fibres was investigated.

The spinning solutions were prepared by dissolving the required amount of PLGA
into the graphene stock dispersion (see experimental section 4.2.3). Using this
method it was possible to systematically control the loading of graphene in the
spinning formulation as well as achieving high volume fraction of graphene in the
final fibres. Figure 4.11 compares optical microscopy images of the graphene
dispersion with the PLGA-graphene composite. The addition of PLGA to the
graphene dispersion did not cause any aggregation of graphene flakes (Figure 4.11B). Optical microscopy images confirmed that there was no agglomeration of the
graphene flakes after production of the composite formulation.
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Figure 4.11. Optical microscopy images of: A) dispersed graphene in CHP (0.5 wt.
%), B) PLGA-graphene composite in CHP (solution containing 1.5 wt. % PLGA and
0.5 wt. % graphene).

4.3.6. Wet-spinning of fibres containing the highest loading of graphene
One role of PLGA in solution is to increase the viscosity of the solution and
consequently provide spinnability. Figure 4.12 compares the viscosity of PLGA and
PLGA-graphene composite solutions as a function of solution concentration (from
1.0 wt% to 5.0 wt% of PLGA). As, the concentration of PLGA in CHP increases
from 1.0 wt. % to 5.0 wt. %, the viscosity increases from 0.015 Pa s to 0.069 Pa s
(Figure 4.12-A).
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Figure 4.12. Viscosity vs shear rate of solutions as a function of PLGA
concentration. The mass percentage of PLGA in each solution are indicated next to
the corresponding graph in pictures A and B. A) PLGA-only solutions. B) Various
concentrations of PLGA dissolved in 5.0 mg/ml graphene CHP stock dispersion (~
0.5 wt. %). C) Comparison of the viscosity of PLGA and PLGA-graphene solutions
as a function of PLGA loading in solution at 100 Pa s shear rate, since the curves
levelled out at this shear rate.
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All prepared solutions were tested for wet-spinning in order to measure the lowest
viscosity (concentration) required for wet-spinning of PLGA solutions. The lowest
concentration of PLGA in a spinning solution should result in the highest mass
fraction of graphene in the final fibre. The results showed that the lowest viscosity of
PLGA required for wet-spinning of continuous PLGA fibres was 0.023 Pa s,
corresponding to a PLGA-only concentration of 2.5 wt. %. However, the addition of
graphene to the spinning solutions resulted in an increase in the viscosity. Comparing
the viscosities of wet-spinnable PLGA-only with PLGA-graphene solutions suggests
that a minimum concentration of 1.5 wt. % of PLGA in the composite spinning
solution is required. A concentration of 1.5 wt. % and above can provide viscosity of
≥ 0.023 Pa s which was found to be spinnable.
Figure 4.13 shows SEM micrographs of PLGA-graphene composite fibres with
diameter of 105±6.0 µm obtained from wet-spinning of a solution containing 1.5 wt.
% of PLGA and 0.5 wt. % of graphene (0.5 wt. % stock solution of graphene). The
surface morphology of the PLGA-graphene composite fibres indicates a smooth
surface topography; however, graphene flakes are visible on the cross section of the
composite fibre. The observed layered structure, as in the cross-section, is due to the
presence of graphene flakes. The image at higher magnification clearly shows
homogeneous incorporation of graphene flakes in the composite fibre, confirming the
compatibility of the composite formulation and the stability of the graphene even
after the spinning process.
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Figure 4.13. A) SEM micrographs of PLGA-graphene composite fibres obtained
from wet-spinning of a spinning solution containing 1.5 wt. % PLGA and 0.5 wt. %
graphene. B) The cross-sectional FE-SEM images of PLGA/graphene composite
fibre confirmed that the graphene flakes were well blended in the composite fibre.

4.3.7. Measuring the mass fraction of graphene from fibres
In order to measure the final mass fraction of graphene in the composite fibres,
thermal gravimetric analysis (TGA) was employed. Figure 4.14 shows TGA graphs
of dried PLGA-graphene fibres as a function of graphene loading. The measured
loadings obtained from TGA are listed in Table 4.1 and compared with the estimated
loadings (calculated from the initial spinning solution compositions). The results
show a promising correlation between the estimated fractions of graphene in dried
fibres with the values measured from TGA graphs.
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Figure 4.14. TGA graphs of PLGA fibres, graphene paper and PLGA-graphene
fibres with different loading percentages of graphene. The measured percentage of
graphene in each composite fibre was obtained from TGA traces at 480 oC as
indicated on the graph by a dashed line.

Table 4.1. Comparisons between the measured graphene loadings obtained from
TGA graphs with the estimated loadings of graphene calculated from the initial
spinning solution compositions.
PLGA concentration in the
spinning solution
(wt. %)
1.5
2
2.5
3
4
5

Estimated loading of
graphene in dried fibres
(wt. %)*
25
20
16.6
14.3
11.1
9.1

Measured loading of graphene
in dried fibres using TGA data
(wt. %)#
24.3
19.6
16.8
13.1
11.1
9.2

* The estimated amount of graphene is based on the ratio of PLGA added to the stock solution of
graphene (0.5 wt. %).
# The measured values were obtained from the TGA traces in Figure 4.14.
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4.3.8. Mechanical characterisation of PLGA-graphene fibres
The mechanical properties of PLGA-graphene fibres were evaluated using stressstrain curves (Figure 4.15). Increasing the loading of graphene resulted in significant
enhancement in tensile modulus and ultimate stress of composite fibres. At the
highest loading (24.3 wt. %) the Young’s modulus and tensile strength increased
significantly up to 13.6±1.3 GPa and 103 MPa, respectively (647 and 59 folds,
respectively) (Table 4.2). The improvement in the mechanical properties can
possibly be attributed to the strong interfacial interactions between graphene flakes
and the polymer matrix due to the bonding between the functional groups on the
edges of the graphene sheets and the hydroxyl groups of the PLGA polymer [53]. On
the other hand, when graphene was introduced as filler the strain at break of the
fibres dropped due to the loading effect of the graphene in the PLGA matrix [53].
Other similar work has reported 2 and 4 times improvement of the modulus and
tensile strength of polyethylene terephthalate fibres respectively, after the addition of
~ 2 wt. % of NMP dispersed graphene [29]. Polyvinyl alcohol-graphene composite
from NMP dispersed graphene has resulted in doubling of the modulus and strength
of a composite film (loadings <0.4 vol% graphene) [30]. Higher improvement in the
mechanical properties of PLGA-graphene fibres reported here is due to higher
loading of graphene in the fibres, which were obtained from a high concentration of
graphene/CHP dispersion.
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Figure 4.15. Stress-strain curves of PLGA-graphene fibres with different loading
percentages of graphene. The numbers represent mass percentage of graphene in the
final composite fibres (data obtained from TGA traces in Figure 4.14)

Table 4.2. Mechanical properties of PLGA and PLGA-graphene fibres with different
loading percentages of graphene using stress-strain curves.
Graphene content
Young’s modulus
Ultimate stress
(wt. %)
(GPa)
(MPa)
0
0.021±0.003
0.58±0.04
9.2
1.22±0.46
24.3±4
11.1
3.11±0.45
51.2±5
13.1
5.23±0.74
61.7±6
16.8
6.14±0.85
78.7±7
19.6
7.51±1.1
87.1±8
24.3
13.6±1.3
103±5
# The mechanical properties data in the table are averages of 10 measurements.

Strain at break
(%)
121±25
24±3
5.3±0.9
1.9±0.4
2.2±0.3
1.9±0.4
0.87±0.2

4.3.9. Electrical conductivity of PLGA-graphene fibres
By adding graphene to the PLGA fibres (more than 11.1 wt. %), conductivity was
induced in the composite system and enhanced by increasing the graphene content

173

(Figure 4.16). Beyond the percolation threshold (11.1 wt. %), the conductivity
increased from ~30 S/m to 150 S/m by increasing the loading of the graphene up to
24.3 wt. %. In this system, which includes a non-conducting matrix and conducting
filler, the non-conducting matrix limits the charge transfer between the graphene
sheets. This is due to the fact that the insulator-coating on graphene results in
enhanced contact resistance between the adjacent graphene sheets [54]. Therefore,
much lower conductivity obtained from the composite fibres compared to the freestanding graphene paper. However, the conductivity (150 S/m) was more than 5
orders of magnitude higher than carbon nanofibres-PLGA composite nanofibres [55]
and 6 orders of magnitude higher than multi-walled carbon nanotube-PLGA
nanofibres [56]. Therefore, PLGA-graphene fibres with highest conductivity and
graphene content were selected for further tests.

Figure 4.16. Conductivity of PLGA-graphene fibres as a function of graphene
content.
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4.3.10. Electrochemical characterisation of PLGA-graphene fibres
The cyclic voltammogram (CV) of PLGA-graphene fibres (24.3 wt. %) (Figure 4.17)
demonstrates the effect of graphene nanosheets as organic conductors in inducing the
electrochemical activity of the fibres. The CV of PLGA-graphene fibres in PBS,
which has not been reported in literature so far, confirms the electroactive properties
of fibres and shows promise for applying these fibres in biomedical applications.

Figure 4.17. Cyclic voltammogram of PLGA-graphene fibres (24.3 wt. %) in PBS as
a function of different scan rates (from 10 mV/s to 100 mV/s, Ei = -0.2 V and Ef =
0.8 V). Arrows show the direction of the potential scan.
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4.3.11. In vitro biocompatibility characterisation of PLGA-graphene fibres
Calcein AM staining imaging of C2C12 on the fibres
In order to confirm the ability to utilise these fibres as biomaterials, the cytotoxicity
of fibres was investigated using C2C12 muscle cells. A tissue culture plate was used
as control in Calcein AM assay. Studies showed that pristine PLGA did not exhibit
cytotoxicity against C2C12 myoblast cells [57, 58] .Figure 4.18 shows the results of
calcein AM staining on C2C12 cells revealing metabolically active cells. The results
show that cells attached to the fibres and spread along their length well.

Figure 4.18. Calcein AM stained C2C12 cells on PLGA-graphene fibres (24.3 wt. %
graphene loading) after 3 days, green spots represent live cells. A) 10X and B) 20X.

Cryo-SEM imaging of C2C12 cells on the fibres.
Cryo-SEM images of the fibres (Figure 4.19) also show C2C12 myoblast cell
attachment and growth. The areas marked with white arrows in Figure 4.19-D show
C2C12 myoblast cells attached on the fibres and spread according to the topology of
the fibres. Figure 4.19-E illustrates the bridging between myoblast cells. Moreover,
attachment and growth of C2C12 cells in direct contact with PLGA-graphene on
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fibres (Figure 4.19-F) evaluate the cytotoxicity of PLGA-graphene fibres for C2C12
myoblast cells. Li et al. studied the toxicity of different biodegradable graphene
derivatives with/out different coatings and showed that graphene oxide with/out
coatings has higher toxicity risk compare to reduced graphene oxide [59]. They
confirmed that graphene oxide had highest level of toxicity against three different
cell lines, human liver cell line, HL-7702, human lung fibroblast cell line MRC-5,
and human macrophage line U937, after they incubated for 72 hr on different
graphene derivatives [59]. Yang et al. utilised ultra-small reduced graphene oxide
with poly ethylene glycol functionalization in phototherapies of cancer [60].
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Figure 4.19. Cryo-SEM images of PLGA-graphene fibres with C2C12 myoblast cells
on them at different magnifications. The white arrows in image D illustrate the
attachment and spread of C2C12 cells on the fibre. The white arrows in image E
shows cell-to-cell bridging on the PLGA-graphene fibre. The white arrows in image
F represent the growth of cells on graphene nanosheets.
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Viability test on C2C12 cells of fibres
C2C12 myoblast cells grown on the PLGA-graphene fibres and on glass slides (as a
control) were subjected to a Pico green assay to characterise the viability of cells
quantitatively. Figure 4.20 presents the number of viable cells on the fibres and glass
slide within three days and shows the growth of cells increased (p* < 0.05) over a 72
hr period on fibres however there was no significant difference in cell growth
between fibres or glass slide after 72 hr. These results confirm the proliferation of
C2C12 cells on fibres and glass slides. To conclude, the cells were keen to proliferate
over 72 hr on PLGA-graphene fibres.

Figure 4.20. Pico green cell number assay on C2C12 myoblast cells on PLGAgraphene fibres and glass slide within 72 hr. The stars represent 95% significant
confidence level in ANOVA t-test and the bars show selected groups for comparison.
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4.4. Conclusion
It has been demonstrated that employing thermally expanded graphite instead of
natural graphite as precursor for solvent exfoliation of graphene results in much
lower sonication time and much higher graphene concentration, with a stable
dispersion obtained. Thermal expansion removes most of the functional groups and
results in improved maintenance of electronic properties of the final graphene sheets.
This preservation of electronic properties was utilised to prepare PLGA-graphene
fibres with high electrical conductivity and electrochemical activity. The PLGAgraphene fibres had a conductivity of ~30 S/m with 11.1 wt. % graphene loading and
it increased to 150 S/m when the graphene content was 24.3 wt. %. The composite
fibres possessed appropriate mechanical properties; with Young’s modulus between
1.22±0.46 to 13.6±1.3 GPa depended on the loading of graphene. Additionally, the
calcein AM fluorescent staining and Cryo-SEM images showed that C2C12
myoblast cells were metabolically active, attached to the surface of fibres and spread
along it. The results of Pico green cell number assay also showed that cells were
active and proliferated along the fibres during 72 hr.

180

4.5. References

[1]
Quigley AF, Razal JM, Kita M, Jalili R, Gelmi A, Penington A, OvalleRobles R, Baughman RH, Clark GM, Wallace GG, Kapsa RMI. "Electrical
Stimulation of Myoblast Proliferation and Differentiation on Aligned Nanostructured
Conductive Polymer Platforms". Advanced Healthcare Materials. 2012;1(6):801-8.
[2]
Esrafilzadeh D, Razal JM, Moulton SE, Stewart EM, Wallace GG.
"Multifunctional conducting fibres with electrically controlled release of
ciprofloxacin". Journal of Controlled Release. (0).
[3]
Luo S-C. "Conducting Polymers as Biointerfaces and Biomaterials: A
Perspective for a Special Issue of Polymer Reviews". Polymer Reviews.
2013;53(3):303-10.
[4]
Razal JM, Gilmore KJ, Wallace GG. "Carbon nanotube biofiber formation in
a polymer-free coagulation bath". Adv Funct Mater. 2008;18(1):61-6.
[5]
Granero AJ, Razal JM, Wallace GG, in het Panhuis M. "Conducting gelfibres based on carrageenan, chitosan and carbon nanotubes". Journal of Materials
Chemistry. 2010;20(37):7953-6.
[6]
Zong X, Bien H, Chung C-Y, Yin L, Fang D, Hsiao BS, Chu B, Entcheva E.
"Electrospun fine-textured scaffolds for heart tissue constructs". Biomaterials.
2005;26(26):5330-8.
[7]
Moulton SE, Higgins MJ, Kapsa RMI, Wallace GG. "Organic Bionics: A
New Dimension in Neural Communications". Advanced Functional Materials.
2012:n/a-n/a.
[8]
G.Wallace G, Moulton S, Kapsa RMI, MichaelHiggins. Organic Bionics.
Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA
2012.
[9]
Fan H, Wang L, Zhao K, Li N, Shi Z, Ge Z, Jin Z. "Fabrication, Mechanical
Properties, and Biocompatibility of Graphene-Reinforced Chitosan Composites".
Biomacromolecules. 2010;11(9):2345-51.
[10] Geim AK, Novoselov KS. "The rise of graphene". Nat Mater. 2007;6(3):18391.
[11] Chen H, Müller MB, Gilmore KJ, Wallace GG, Li D. "Mechanically Strong,
Electrically Conductive, and Biocompatible Graphene Paper". Advanced Materials.
2008;20(18):3557-61.
[12] van den Brink J. "Graphene: What lies between". Nat Mater. 2010;9(4):2912.
[13] Balog R, Jorgensen B, Nilsson L, Andersen M, Rienks E, Bianchi M, Fanetti
M, Laegsgaard E, Baraldi A, Lizzit S, Sljivancanin Z, Besenbacher F, Hammer B,
Pedersen TG, Hofmann P, Hornekaer L. "Bandgap opening in graphene induced by
patterned hydrogen adsorption". Nat Mater. 2010;9(4):315-9.
[14] Lee C, Wei X, Kysar JW, Hone J. "Measurement of the Elastic Properties
and Intrinsic Strength of Monolayer Graphene". Science. 2008;321(5887):385-8.
[15] Hernandez Y, Nicolosi V, Lotya M, Blighe FM, Sun Z, De S, McGovern IT,
Holland B, Byrne M, Gun'Ko YK, Boland JJ, Niraj P, Duesberg G, Krishnamurthy S,
Goodhue R, Hutchison J, Scardaci V, Ferrari AC, Coleman JN. "High-yield
production of graphene by liquid-phase exfoliation of graphite". Nat Nano.
2008;3(9):563-8.

181

[16] Novoselov KS, Geim AK, Morozov SV, Jiang D, Zhang Y, Dubonos SV,
Grigorieva IV, Firsov AA. "Electric Field Effect in Atomically Thin Carbon Films".
Science. 2004;306(5696):666-9.
[17] Sutter PW, Flege J-I, Sutter EA. "Epitaxial graphene on ruthenium". Nat
Mater. 2008;7(5):406-11.
[18] Kosynkin DV, Higginbotham AL, Sinitskii A, Lomeda JR, Dimiev A, Price
BK, Tour JM. "Longitudinal unzipping of carbon nanotubes to form graphene
nanoribbons". Nature. 2009;458(7240):872-6.
[19] Amini S, Garay J, Liu G, Balandin AA, Abbaschian R. "Growth of largearea graphene films from metal-carbon melts". Journal of Applied Physics.
2010;108(9):094321--7.
[20] Choucair M, Thordarson P, Stride JA. "Gram-scale production of graphene
based on solvothermal synthesis and sonication". Nat Nano. 2009;4(1):30-3.
[21] Sun Z, Yan Z, Yao J, Beitler E, Zhu Y, Tour JM. "Growth of graphene from
solid carbon sources". Nature. 2010;468(7323):549-52.
[22] Nuvoli D, Valentini L, Alzari V, Scognamillo S, Bon SB, Piccinini M,
Illescas J, Mariani A. "High concentration few-layer graphene sheets obtained by
liquid phase exfoliation of graphite in ionic liquid". Journal of Materials Chemistry.
2011;21(10):3428-31.
[23] Lotya M, Hernandez Y, King PJ, Smith RJ, Nicolosi V, Karlsson LS, Blighe
FM, De S, Wang Z, McGovern IT, Duesberg GS, Coleman JN. "Liquid Phase
Production of Graphene by Exfoliation of Graphite in Surfactant/Water Solutions".
Journal of the American Chemical Society. 2009;131(10):3611-20.
[24] Cui X, Zhang C, Hao R, Hou Y. "Liquid-phase exfoliation, functionalization
and applications of graphene". Nanoscale. 2011;3(5):2118-26.
[25] Behabtu N, Lomeda JR, Green MJ, Higginbotham AL, Sinitskii A, Kosynkin
DV, Tsentalovich D, Parra-Vasquez ANG, Schmidt J, Kesselman E, Cohen Y,
Talmon Y, Tour JM, Pasquali M. "Spontaneous high-concentration dispersions and
liquid crystals of graphene". Nat Nano. 2010;5(6):406-11.
[26] Stankovich S, Dikin DA, Dommett GHB, Kohlhaas KM, Zimney EJ, Stach
EA, Piner RD, Nguyen ST, Ruoff RS. "Graphene-based composite materials".
Nature. 2006;442(7100):282-6.
[27] Hernandez Y, Nicolosi V, Lotya M, Blighe FM, Sun Z, De S, McGovern IT,
Holland B, Byrne M, Gun'Ko YK, Boland JJ, Niraj P, Duesberg G, Krishnamurthy S,
Goodhue R, Hutchison J, Scardaci V, Ferrari AC, Coleman JN. "High-yield
production of graphene by liquid-phase exfoliation of graphite". Nat Nanotechnol.
2008;3(9):563-8.
[28] Coleman JN. "Liquid Exfoliation of Defect-Free Graphene". Accounts of
Chemical Research. 2012.
[29] Khan U, Young K, O'Neill A, Coleman JN. "High strength composite fibres
from polyester filled with nanotubes and graphene". Journal of Materials Chemistry.
2012;22(25):12907-14.
[30] May P, Khan U, O'Neill A, Coleman JN. "Approaching the theoretical limit
for reinforcing polymers with graphene". Journal of Materials Chemistry.
2012;22(4):1278-82.
[31] Zhao X, Zhang Q, Chen D, Lu P. "Enhanced Mechanical Properties of
Graphene-Based
Poly(vinyl
alcohol)
Composites".
Macromolecules.
2010;43(5):2357-63.
[32] Lu HH, Cooper Jr JA, Manuel S, Freeman JW, Attawia MA, Ko FK,
Laurencin CT. "Anterior cruciate ligament regeneration using braided
182

biodegradable scaffolds: in vitro optimization studies". Biomaterials.
2005;26(23):4805-16.
[33] Jonathan NC. "Liquid-Phase Exfoliation of Nanotubes and Graphene".
Advanced Functional Materials. 2009;19(23):3680-95.
[34] Lotya M, King PJ, Khan U, De S, Coleman JN. "High-Concentration,
Surfactant-Stabilized Graphene Dispersions". ACS Nano. 2010;4(6):3155-62.
[35] Khan U, O'Neill A, Lotya M, De S, Coleman JN. "High-Concentration
Solvent Exfoliation of Graphene". Small. 2010;6(7):864-71.
[36] Bourlinos AB, Georgakilas V, Zboril R, Steriotis TA, Stubos AK. "LiquidPhase Exfoliation of Graphite Towards Solubilized Graphenes". Small.
2009;5(16):1841-5.
[37] Aboutalebi SH, Gudarzi MM, Zheng QB, Kim J-K. "Spontaneous Formation
of Liquid Crystals in Ultralarge Graphene Oxide Dispersions". Advanced Functional
Materials. 2011;21(15):2978-88.
[38] Hernandez Y, Lotya M, Rickard D, Bergin SD, Coleman JN. "Measurement
of Multicomponent Solubility Parameters for Graphene Facilitates Solvent
Discovery". Langmuir. 2009;26(5):3208-13.
[39] Bergin SD, Sun Z, Streich P, Hamilton J, Coleman JN. "New Solvents for
Nanotubes: Approaching the Dispersibility of Surfactants". The Journal of Physical
Chemistry C. 2009;114(1):231-7.
[40] Blake P, Brimicombe PD, Nair RR, Booth TJ, Jiang D, Schedin F,
Ponomarenko LA, Morozov SV, Gleeson HF, Hill EW, Geim AK, Novoselov KS.
"Graphene-Based Liquid Crystal Device". Nano Letters. 2008;8(6):1704-8.
[41] Coleman JN. "Liquid Exfoliation of Defect-Free Graphene". Accounts of
Chemical Research. 2012;46(1):14-22.
[42] Bergin SD, Sun Z, Streich P, Hamilton J, Coleman JN. "New Solvents for
Nanotubes: Approaching the Dispersibility of Surfactants". J Phys Chem C.
2010;114(1):231-7.
[43] Sun Z, Hasan T, Torrisi F, Popa D, Privitera G, Wang F, Bonaccorso F,
Basko DM, Ferrari AC. "Graphene Mode-Locked Ultrafast Laser". ACS Nano.
2010;4(2):803-10.
[44] Ferrari AC, Meyer JC, Scardaci V, Casiraghi C, Lazzeri M, Mauri F,
Piscanec S, Jiang D, Novoselov KS, Roth S, Geim AK. "Raman Spectrum of
Graphene and Graphene Layers". Physical Review Letters. 2006;97(18):187401.
[45] Meyer JC, Geim AK, Katsnelson MI, Novoselov KS, Obergfell D, Roth S,
Girit C, Zettl A. "On the roughness of single- and bi-layer graphene membranes".
Solid State Communications. 2007;143(1–2):101-9.
[46] Olek M, Ostrander J, Jurga S, Möhwald H, Kotov N, Kempa K, Giersig M.
"Layer-by-Layer Assembled Composites from Multiwall Carbon Nanotubes with
Different Morphologies". Nano Letters. 2004;4(10):1889-95.
[47] Sweetman LJ, Nghiem L, Chironi I, Triani G, in het Panhuis M, Ralph SF.
"Synthesis, properties and water permeability of SWNT buckypapers". Journal of
Materials Chemistry. 2012;22(27):13800-10.
[48] Yan M, Tallman DE, Bierwagen GP. "Role of oxygen in the galvanic
interaction between polypyrrole and aluminum alloy". Electrochimica Acta.
2008;54(2):220-7.
[49] Aboutalebi SH, Aminorroaya-Yamini S, Nevirkovets I, Konstantinov K, Liu
HK. "Enhanced Hydrogen Storage in Graphene Oxide-MWCNTs Composite at
Room Temperature". Adv Energy Mater. 2012;2(12):1439-46.

183

[50] Aboutalebi SH, Chidembo AT, Salari M, Konstantinov K, Wexler D, Liu
HK, Dou SX. "Comparison of GO, GO/MWCNTs composite and MWCNTs as
potential electrode materials for supercapacitors". Energ Environ Sci.
2011;4(5):1855-65.
[51] Polschikov SV, Nedorezova PM, Klyamkina AN, Kovalchuk AA, Aladyshev
AM, Shchegolikhin AN, Shevchenko VG, Muradyan VE. "Composite materials of
graphene nanoplatelets and polypropylene, prepared by in situ polymerization".
Journal of Applied Polymer Science. 2013;127(2):904-11.
[52] Li Z, Zhou M-R, Zhang T, Zhang J, Yang L, Zhou Z-n. "The Facile Synthesis
of Graphene Nanoplatelets and Lead Styphnate Composites for the Depressed
Electrostatic Hazards". Journal of Materials Chemistry A. 2013.
[53] Yoon O, Sohn I, Kim D, Lee N-E. "Enhancement of thermomechanical
properties of poly(D,L-lactic-co-glycolic acid) and graphene oxide composite films
for scaffolds". Macromol Res. 2012;20(8):789-94.
[54] Kilbride BE, Coleman JN, Fraysse J, Fournet P, Cadek M, Drury A, Hutzler
S, Roth S, Blau WJ. "Experimental observation of scaling laws for alternating
current and direct current conductivity in polymer-carbon nanotube composite thin
films". Journal of Applied Physics. 2002;92(7):4024-30.
[55] Stout DA, Basu B, Webster TJ. "Poly(lactic–co-glycolic acid): Carbon
nanofiber composites for myocardial tissue engineering applications". Acta
Biomaterialia. 2011;7(8):3101-12.
[56] Hualin Zhang, Zhiqing Chen. "Fabrication and Characterization of
Electrospun PLGA/MWNTs/ Hydroxyapatite Biocomposite Scaffolds for Bone Tissue
Engineering". Journal of Bioactive and Compatible Polymers. 2010;25(3):241-59.
[57] T. A, Hassan M.S, Nam K., Bing Y.Y., Barakat A. N, Khil M, Kim H, .
"Preparation, characterization, and cytotoxicity of CPT/Fe2O3-embedded PLGA
ultrafine composite fibers: a synergistic approach to develop promising anticancer
material". International Journal of Nanomedicine. 2012;7:1659-70.
[58] Aviss K.J., Gough J.E., Downes S., " Aligned electrospun polymer fibres for
skeletal muscle regeneration". European Cells and Materials. 2010;19:193-204.
[59] Li Y, Feng L, Shi X, Wang X, Yang Y, Yang K, Liu T, Yang G, Liu Z.
"Surface coating-dependent cytotoxicity and degradation of graphene derivatives:
Towards the design of non-toxic, degradable nano-graphene". Small.
2014;10(8):1544-54.
[60] Yang K, Wan J, Zhang S, Tian B, Zhang Y, Liu Z. "The influence of surface
chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer
using ultra-low laser power". Biomaterials. 2012;33(7):2206-14.

184

185

5 SUMMARY AND CONCLUSION
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The main aim of this thesis was to design and develop three-dimensional conducting
biomaterials using wet-spinning and electrospinning in order to be utilised in
biomedical applications. Multifunctional conducting wet-spun fibres such as
PEDOT:PSS-CHI,

PEDOT:PSS-CHI-PPy.Cipro

and

PLGA-graphene

were

fabricated. In addition, a novel spinning strategy which combines electrospinning
and

wet-spinning

was

developed

to

fabricate

PEDOT:PSS-CHI-PLGA

nanostructured fibres. All of the materials developed and fibres produced were
thoroughly studied for their spinnability, mechanical properties, electrical
conductivity, electrochemical behaviour and in vitro biocompatibility properties.
Some of the potential applications of these fibres were demonstrated such as
controlled drug release and as supports for cellular growth. The outcome and
conclusions of this thesis are summarised and reviewed in the following sections:Chapter 2: Multi-functional conducting wet-spun fibres for controlled release of
ciprofloxacin
The fabrication of conducting fibres using the conducting polymer PEDOT:PSS was
performed using the wet-spinning approach which was subsequently utilised for the
controlled delivery of an anitibiotic, Ciprofloxacin. This work demonstrated that
highly conducting wet-spun fibres of PEDOT:PSS can be fabricated when using
chitosan as coagulation solution. It was found that optimal wet-spinning parameters
including feed rate, coagulation composition and size of spinneret are key factors that
affect the production of continuous and conducting fibres. Although, chitosan was
utilized as coagulation agent to form PEDOT:PSS fibres, it was found that chitosan
only contributed around 3.5 % of the total mass of PEDOT:PSS-CHI. This low
proportion of chitosan ensured that the conductivity of the fibres formed was not
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compromised. The fibres demonstrated electrical conductivity of 56 ± 7 Scm-1 after
treatment with ethylene glycol.

The high conductivity of these fibres facilitated their subsequent use as an electrode
upon which it was possible to electrochemically synthesis a second layer of
conducting

polymer

(polypyrrole)

containing

the

antibiotic

ciprofloxacin

hydrochloride (Ppy.cipro) as a dopant. The thickness of the Ppy.Cipro layer was
tuned by varying current density and time of electropolymerisation, which also
resulted in different loadings of drug in the Ppy.Cipro layer. The cyclic
voltammogram (CV) of fibres demonstrated electro-activity in PBS, which was
essential for the further applications of the fibres to control drug release. The cyclic
voltammogram of PEDOT:PSS-CHI-Ppy.Cipro fibres revealed oxidation and
reduction peaks at +0.2 V and -0.1 V, respectively, that were utilised later on for the
electrical stimulation of fibres to control cipro release. The impedance spectrum of
fibres in PBS showed their lower resistivity (~2.8 kΩ/cm2) at 1 kHz (relevant
frequency of biological activities) compared with Pt wire (~ 10.3 kΩ/cm2), thus
confirming the suitability of the fibres as Pt wire replacement.

The release of cipro from the fibres was controlled using electrical stimulation over a
72 hr timeframe. The release profile demonstrated a doubling of the mass of cipro
released when the fibres were electrically held in their reduced state compared to the
passive (non-stimulated) state. It was also shown that it is possible to reduce the
passive release by 20% by applying a voltage that held the fibre in an oxidised state.
Moreover, the ability to switch between reduced and oxidised states of the fibres to
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control the turning on/off of the cipro release demonstrated the potential of these
fibres to modulate the release profiles.

The antibacterial efficacy of cipro (in the fibre as well as when released) was tested
to confirm that the antibiotic property of the cipro was retained after electrochemical
polymerisation and electrically stimulated release. The presence of a zone of
inhibition surrounding the fibres (PEDOT:PSS-CHI-Ppy.Cipro) against two different
types of bacteria (S. pyogenes and E.coli) demonstrated the antibacterial property of
the fibres after electrochemical polymerisation. In addition, different sizes of zone of
inhibitions were found when the release aliquots were in contact with S. pyogenes
and E.coli which correlated with the amount of cipro released from the fibre
(contained in each aliquot). These results confirmed that the antibacterial property of
cipro was retained.

The biocompatibility of PEDOT:PSS-CHI and PEDOT:PSS-CHI-Ppy.Cipro fibres
was tested using the B35 neuroblastoma cells model. The results demonstrated that
neither the fibres or the released cipro are toxic for neural cells, however, it was
observed that the neural cells did not attach to the surface of either the PEDOT:PSSCHI nor PEDOT:PSS-CHI-Ppy.Cipro fibres well and preferred to agglomerate to
each other rather than spread along the fibres.
The PEDOT:PSS-CHI-Ppy.Cipro fibres, because of their favourable physical and
electrochemical behaviour as well as antibacterial and biocompatibility properties,
demonstrate their suitability for use in biomedical applications.
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Chapter 3: Combined wet-spinning and electrospinning: new fabrication method to
enhance bio-compatibility of conducting fibres
A novel fabrication technique was developed in an attempt to improve the
biocompatibility of PEDOT:PSS-CHI wet-spun fibres and enhance the adhesion of
B35 neural cells to the fibres. The wet-spinning system was modified by introducing
an electrospinning component to the method. Combined wet-spinning and
electrospinning was utilised as a new technique to fabricate a conducting or nonconducting 3D architecture depending on the requirements of the final structure.

The combined simultaneous wet-spinning and electrospinning method put to use the
two techniques whereby the fabricated micro wet-spun conducting PEDOT:PSS-CHI
fibres are covered with a porous PLGA electrospun layer. The physical
characterisation of these PEDOT:PSS-CHI-PLGA fibres revealed a porous PLGA
electrospun sheath with diameter of 1.64 ± 0.6 μm which was wrapped continuously
around the wet-spun fibre. The thickness of the PLGA electrospun sheath could be
tuned by varying the electrospinning pumping rate. The electrochemical
characterisation (CV in PBS) of the fibres showed that the electrospun sheath does
not hinder the transfer of ions from the PBS into the conducting PEDOT:PSS-CHI
micro-fibre core.
The drug delivery application of these novel fibres was demonstrated using
ciprofloxacin release from the PLGA electrospun sheath. The release profile
indicated that the cipro release within the first 28 days was due to diffusion of cipro
from the PLGA electrospun sheath. Neural cell attachment onto fibres was revealed
by fluorescent imaging techniques and confirmed cell attachment to the surface of
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fibres and that the cells also migrated into the electrospun sheath, proliferating and
differentiating into the structure. Moreover, the electrospun sheets acted as a guide
for neural cells since the size and specific geometry of PLGA electrospun sheets
facilitated the attachment of the axons of the B35 neural cells that mimicked the
direction of the fibres.
This chapter demonstrated a novel and facile technique for the production of
PEDOT:PSS-CHI-PLGA fibres, characterisations of these novel fibres as well as
their capability to release drug or support cell growth.

Chapter 4: Wet-spinning of multifunctional PLGA-graphene fibres
The production and application of graphene in fabricating conducting bio-fibres were
the main aims of this chapter. The production method of graphene was liquid phase
exfoliation of graphene in organic solvent through bath sonication. It was found that
the concentration and quality of the produced graphene was dependent on various
parameters such as solvent and the sonication time. Initial solid-state exfoliation of
graphite, through thermal expansion of graphite, facilitated the diffusion of solvent
between the graphene layers and resulted in more efficient solvent exfoliation of
graphene.

It was demonstrated that NMP, which was reported to be the most efficient solvent
for graphene, is not effective when expanded graphite is used as precursor. However,
cyclohexyl-pyrrolidone (CHP) effectively dispersed high concentrations of graphene
(up to 5 mg/ml) at much lower sonication times compared to literature reports on
solvent exfoliation of graphene. It is suggested in this thesis that the origin of this
phenomenon is due to the difference between defects and functionalities in natural
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graphite and expanded graphite. Raman spectroscopy studies showed that natural
graphite contains a portion of defects and functionalities, represented by the D band
in its Raman spectra, whereas the spectra of expanded graphite does not contain a D
band. It has been established that, as the sonication time increased it was possible to
disperse more graphene into the solvent; until achieving the highest concentration at
~5 mg/ml after 96 hr sonication. Transmission electron microscopy (TEM) analysis
showed that the graphene dispersion contained both monolayer and multilayers
graphene. The processability of the solvent exfoliated graphene was shown by
preparing free-standing robust, flexible and highly conducting graphene paper using
vacuum filtration. SEM analysis confirmed that the free-standing graphene paper
contain graphene flakes that are well-aligned in the plane of the paper. The
comparison between the Raman spectra (2D peak) of graphite and graphene freestanding paper shows that, while the graphene needs aggregates to form the paper,
the flakes do not restack in a fully ordered assembly similar to graphite. Raman study
of the free-standing graphene paper showed 2D bands reported for graphene flakes of
three to five layers. The free-standing graphene paper also had a superior
conductivity to those previously reported; which was due to the defect free nature of
expanded graphite (graphene precursor).

The high conductivity of the produced graphene made this material an excellent
choice for the production of highly conducting composites. Therefore, the solvent
exfoliated graphene was added to PLGA to produce an electrically conductive
composite. The wet-spinning method was used to spin electrically conductive and
robust graphene-PLGA composite fibres. Systematic control of graphene loading in
the spinning solution was achieved by dissolving the required amount of PLGA to
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the graphene stock dispersion. The addition of PLGA to the graphene dispersion did
not have an adverse effect on graphene dispersion quality. Comparing the viscosities
of wet-spinnable PLGA with PLGA-graphene solutions suggested that at least 1.5
wt. % of PLGA in the composite spinning solution is required for successful wetspinning to occur and a fibre to form. This composition resulted in the highest mass
loading of graphene of 25 wt. % in the dried fibres (verified by TGA studies). The
PLGA fibre displayed very high strain, however when graphene was added, the fibre
strain decreased while modulus and ultimate stress increased significantly. The
significant drop of strain along with the introduction of conductivity suggests the
formation of a graphene network within the fibres. By adding graphene to the PLGA
fibres, conductivity was induced and increased with increasing graphene loading.
The CV of PLGA-graphene fibre in PBS confirmed the electroactive property of
fibres.

The biocompatibility of the fibres was studied through calcein AM staining on
C2C12 cells. Results showed that cells could attach to the fibres and spread along
their structures and that the specific geometry of the structure (fibre) guided cells to
mimic the direction of fibres (also confirmed by Cryo-SEM studies). The ability to
guide the direction of the cells growth is an attractive feature of these fibres.
Quantitative viability of the C2C12 myoblast cells on the fibres, evaluated using Pico
green assay, confirmed the in vitro biocompatibility of the fibres.
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